Basic Information

Faculty

• Faculty of Medicine

Professional Memberships

• From Apr. 2025, To Present

  Japan Neuroendocrine Tumor Society
• From Aug. 2024, To Present

  Sigma Xi, The Scientific Research Honor Society
• From Jan. 2024, To Present

  Japanese Society for Treatment of Obesity
• From Jan. 2024, To Present

  Japan Society of Experimental Diabetes and Obesity
• From Apr. 2019, To Present

  The Japanese Pancreas and Islet Transplantation Association
• From Apr. 2007, To Present

  The Japanese Society of Internal Medicine
• From Apr. 2007, To Present

  Japan Society for the Study of Obesity
• From Apr. 2013, To Present

  The Japan Society of Constitutional Medicine
• From Apr. 2007, To Present

  The Japan Endocrine Society
• From Apr. 2007, To Present

  Japan Association of Diabetes Education and Care
• From Apr. 2009, To Present

  American Diabetes Association
• From Apr. 2009, To Present

  The European Association for the Study of Diaebtes
• From Apr. 2010, To Present

  The Asian Association for the Study of Diabetes
• From Apr. 2007, To Present

  The Japan Society of Metabolism and Clinical Nutrition
• From Apr. 2007, To Present

  The Japan Diabetes Society
• From Apr. 2021, To Present

  The Japan Association for Medical Informatics
• From Apr. 2019, To Present

  The Japanese Society of Nephrology
• From Apr. 2019, To Present

  Japan College of Rheumatology
• From Apr. 2019, To Present

  The Japanese Society of Diabetes and Pregnancy
• From Apr. 2019, To Present

  The Japanese Society of Ophthalmic Diabetology
• From Apr. 2019, To Present

  The Japanese Society of Informatics for Diabetes Mellitus
• From Apr. 2019, To Present

  The Japan Society of Diabetic Complications

Academic Degree

• 1998

  M.D. (Kyoto University)
• 09 May 2003

  Ph.D. (The University of Texas)

Academic Resume (Graduate Schools)

• The University of Texas, Southwestern Graduate School of Biomedical Sciences, Cell Regulation Program, Completed

Academic Resume (Undergraduate School/Majors)

• Kyoto University, Faculty of Medicine, Graduated

High School

• High School

  St. Viator High School

Research History

• From Apr. 2025, To Present

  Kyoto University, Hospital, Vice President
• From Mar. 2025, To Present

  Gifu University Institute of Advanced Studies, Center for One Medicine Innovative Translational Research, Visiting Professor
• From Apr. 2020, To Mar. 2021

  Gifu University Graduate School of Medicine, Department of Diabetes, Endocrinology and Metabolism, Professor
• From Apr. 2003, To Jan. 2004

  Kyoto University Graduate School of Medicne, Department of Medical Chemistry and Molecular Biology, PD Japan Society for the Promotion of Science
• From Mar. 2024, To Present

  Kyoto University Hospital, Hospital Metabolism and Clinical Nutrition, Director
• From Mar. 2024, To Present

  Kyoto University Hospital, Department of Diabetes, Endocrinology and Nutrition, Director
• From Mar. 2024, To Feb. 2025

  Gifu University Institute of Advanced Studies, Center for One Medicine Innovative Translational Research, Specially Appointed Professor
• From Mar. 2024, To Feb. 2025

  Gifu University, Graduate School of Medicine, Specially Appointed Professor
• From Mar. 2024, To Present

  Kyoto University, Department of Diabetes, Endocrinology and Nutrition, Professor and Chairman
• From Apr. 2022, To Present

  Fujita Health University, Visiting Professor
• From Jul. 2015, To Present

  Kansai Electric Power Medical Research Institute, Deputy Director General
• From Sep. 2023, To Feb. 2024

  Gifu University Institute of Advanced Studies, Artificial Intelligence Advanced Research Center, Professor
• From Apr. 2023, To Feb. 2024

  Tokai Higher Education and Research System, Gifu University Graduate School of Medicine, Assistant to Dean
• From Apr. 2023, To Feb. 2024

  Tokai Higher Education and Research System, Center for One Medicine Innovative Translational Research, Professor, Director
• From Apr. 2023, To Feb. 2024

  Tokai National Higher Education and Research System, Center for research, education, and development for healthcare life design, Professor, Deputy Director
• From Jan. 2023, To Feb. 2024

  Gifu University, Center for One Medicine Innovative Translational Research, Institute of Advanced Studies, Professor, Director
• From Apr. 2022, To Feb. 2024

  Gifu University, Preemptive Food Research Center, Institute of Advanced Studies, Professor, Deputy Director
• From Apr. 2022, To Feb. 2024

  Gifu University, University Hospital, Deputy Director
• From Jul. 2021, To Feb. 2024

  Gifu University Hospital, Division of Medical Informatics, Director
• From Apr. 2021, To Feb. 2024

  Gifu University, Department of Rheumatology and Clinical Immunology, Professor
• From Apr. 2021, To Feb. 2024

  Gifu University, Department of Diabetes, Endocrinology and Metabolism, Graduate School of Medicine, Professor
• From Apr. 2020, To Feb. 2024

  Gifu University Hospital, Center for Global Health and Medicine, Director
• From Dec. 2018, To Feb. 2024

  Gifu University Hospital, Center for Clinical Immunology and Endocrine Disorders, Director
• From Dec. 2018, To Feb. 2024

  Gifu University Hospital, Center for Diabetes and Metabolic Disorders, Director
• From Dec. 2018, To Feb. 2024

  Kyoto University Graduate School of Medicine, Department of Diabetes, Endocrinology and Nutrition, 非常勤講師
• From Jan. 2022, To Mar. 2023

  Gifu University Hospital, Division of Medical Secretary, Director
• From Jul. 2021, To Mar. 2023

  Tokai National Higher Education and Research System, Center for Healthcare Information Technology, Deputy Director
• From Apr. 2020, To Mar. 2023

  Tokai National Higher Education and Research System, 医療健康データ統合研究教育拠点, Professor
• From Apr. 2020, To Mar. 2022

  Gifu University Hospital, University Hospital, Assistant to President
• From Apr. 2019, To Mar. 2022

  Kobe University Graduate School of Medicine, Visiting Professor
• From Dec. 2018, To Mar. 2020

  Gifu University Graduate School of Medicine, Department of Diabetes and Endocrinology, Professor and Chairman
• From Apr. 2011, To Mar. 2019

  Kobe University Graduate School of Medicine, 医学研究科, Visiting Associate Professor
• From Apr. 2016, To Nov. 2018

  Kyoto University Graduate School of Medicine, Department of Diabetes, Endocrinology and Nutrition, Program-Specific Associate Professor
• From Jan. 2013, To Mar. 2016

  Kansai Electric Power Hospital, Center for Diabetes, Endocrinology and Metabolism, Director
• From Jan. 2013, To Mar. 2016

  Kansai Electric Power Hospital, Center for Metabolism and Clinical Nutrition, Chief Director
• From Aug. 2012, To Jan. 2013

  関西電力病院 疾患治療部, 部長
• From Apr. 2009, To Dec. 2012

  Division of Diabetes and Clinical Nutrition, Kansai Electric Power Hospital, Assistant Director
• From Apr. 2007, To Mar. 2009

  Division of Diabetes and Nutrition, Kansai Electric Power Hospital, Physician Scientitst
• From Feb. 2004, To Mar. 2007

  Kyoto University Gradate School of Medicine, Department of Medical Chemistry and Molecular Biology, Assistant Professor

Profile

• Profile

  Dr. Daisuke Yabe has been investigating pathophysiology of type 2 diabetes in Asian population. His clinical research interests include secretion and action of incretins GLP-1 and GIP, as well as clinical safety and efficacy of incretin-based therapies in management of type 2 diabetes. He also studies molecular basis underlying aging of pancreatic beta cells; and beta cell heterogeneity. Dr. Yabe obtained MD degree from Kyoto University Faculty of Medicine (Japan), and PhD degree from the University of Texas Southwestern Graduate School of Biomedical Sciences (USA). Dr. Yabe serves as Professor and Chairman for Department of Diabetes and Endocrinology, Gifu University Graduate School of Medicine (Japan), Deputy Director General for Kansai Electric Power Medical Research Institute (Japan), Visiting Professor for Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine (Japan), and Visiting Scholar for Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine (Japan). While Dr. Yabe is actively involved in clinical and basic research related to diabetes, he is also dedicated for diabetes care and education as a diabetes specialist. He has served as a member of the IDF Science Taskforce, and is currently serving as a member of the IDF-WPR executive committee and a member of the AASD executive committee. He is also an active member of the International Affairs Committee, the Science Committee and the Diabetes Education Committee, The Japan Association for Diabetes Education and Care; and the International Affairs Committee and the Public Relations Committee, The Japan Diabetes Society.

Language of Instruction

• English
• Japanese

ID,URL

• ORCID ID

  0000-0002-5334-7687

• J-Global ID

  201101031993400113

• Researcher number

  60378643

• External link

  https://www.kuhp.kyoto-u.ac.jp/department/departments/den.html

Website(s) (URL(s))

• https://metab-kyoto-u.jp/

researchmap URL

• https://researchmap.jp/dai_yabe

Research

Research Topics, Overview of the research

• Research Topics

  Elucidation of the pathogenesis of diabetes, endocrine and metabolic disorders, and nutrition-related diseases, and establishment of novel preventive and therapeutic strategies.

• Overview of the research

  We are conducting clinical research, basic research, and data science research to elucidate the pathophysiology of diabetes, endocrine metabolic diseases, and nutrition-related diseases such as obesity and sarcopenia and to establish new treatment methods. In clinical research, we hope to promote research that will improve the quality of medical care for diabetes, endocrine metabolic diseases, and nutrition-related diseases, focusing on research on incretin secretion and action and on the developmental mechanisms of neuroendocrine tumors. In basic research, we would like to deepen our understanding of the processes from the acquisition of endocrine cell functions to aging, using pancreatic beta cells as a starting point, and develop basic research that will serve as a foundation for the development of novel preventive and therapeutic strategies.

Research Interests

• Neuroendocrine tumors
• Obesity
• Pancreatic beta cells
• Diabetes education and support
• Endocrine disorders
• Clinical nutrition
• Dislipidemia
• Diabetes
• Incretin

Research Areas

• Life sciences, Physical and health education, Clinical Nutrition
• Life sciences, Metabolism and endocrinology, Neuroendocrine tumors
• Life sciences, Metabolism and endocrinology, Lipidology
• Life sciences, Metabolism and endocrinology, Diabetes
• Life sciences, Pathobiochemistry

Papers

• Qualitative and Quantitative Analyses of Noninvasive Diagnosis of Insulinoma Using [18F]FB(ePEG12)12-exendin-4 PET/CT.

  Murakami T.; Yoshida H.; Sakaki K.; Otani D.; Kawai Miyake K.; Shimizu Y.; Fujimoto H.; Yabe D.; Nakamoto Y.; Inagaki N.

  The Journal of Clinical Endocrinology & Metabolism., Apr. 2025, Peer-reviewed

  
• A Case of Fulminant Type 1 Diabetes With Residual Insulin Secretion.

  Kato T; Harada N; Nishikawa Y; Yamamoto K; Murakami T; Ueda Y; Okamoto M; Yabe D

  Cureus, Apr. 2025, Peer-reviewed, Last author

  
• Longitudinal monitoring of urinary C-peptide levels following discontinuation of Sacubitril/valsartan in a Type 2 diabetes patient: A case report and literature review.

  Kondo K.; Minamino H.; Murakami T.; Okamura E.; Hakata T.; Ueda Y.; Taura D.; Yabe D.

  Diabetology International, Apr. 2025, Peer-reviewed, Last author

  
• Exendin-4 PET for occult insulinoma A case of occult insulinoma localized by [18 F] FB (ePEG12)12-exendin-4 positron emission tomography with negative findings of selective arterial calcium stimulation test.

  Sakaki K.; Murakami T.; Fujimoto H.; Shimizu Y.; Kawai Miyake K.; Otani D.; Otsuki S.; Shimizu H.; Nagai K.; Nomura T.; Yabe D.; Nakamoto Y.; Inagaki N.

  Frontiers in Endocrinology, Apr. 2025, Peer-reviewed

  
• Evolving Incretin-Based Therapies in Japan: Optimizing Treatment Strategies for Diverse Clinical and Socioeconomical Profiles in Type 2 Diabetes.

  Seno Y.; Ikeguchi E.; Yabe D.

  Diabetology International, Apr. 2025, Peer-reviewed, Invited, Last author, Corresponding author

  
• Depression Risk Associated with Spouses’ Diabetes and Cardiovascular Events: A Nationwide Cohort Study.

  Komura T.; Tsugawa Y.; Yabe D.; Kondo N.; Inoue K.

  American Journal of Epidemiology, Apr. 2025, Peer-reviewed

  
• A prediction model for diabetes complications using the Kokuho Database and its application to public health services in Japan

  Shumpei Chiba; Takaaki Itoga; Kazuo Asada; Daisuke Yabe

  Journal of diabetes investigation, 02 Apr. 2025, Peer-reviewed, Last author

  
• Glucose and insulin differently regulate gluconeogenic and ureagenic gene expression

  Kanako DEGUCHI; Chihiro USHIRODA; Yuka KAMEI; Kyosuke KONDO; Hiromi TSUCHIDA; Yusuke SEINO; Daisuke YABE; Atsushi SUZUKI; Shizuko NAGAO; Katsumi IIZUKA

  Journal of nutritional science and vitaminology, 28 Feb. 2025

  
• A Novel Multiple Endocrine Neoplasia Type 1 Gene Variant Found in Scalp Pulmonary Neuroendocrine Tumor Metastasis

  Yoshihiro Takahashi; Yukio Horikawa; Yumi Matsuyama; Kimiko Asai; Junki Endo; Daisuke Yabe

  JCEM Case Reports, 17 Mar. 2025, Peer-reviewed, Last author

  
• Relation between obesity and health disorders as revealed by the J-ORBIT clinical information collection system directly linked to electronic medical records (J-ORBIT 1).

  Seiji N.; Hirota Y.; Yasushi N.; Ishii M.; Ohsugi M.; Maeda E.; Yoshimura K.; Yamamoto A.; Takayoshi T.; Kato T.; Yabe D.; Matsuhisa M.; Eguchi J.; Wada J.; Fujita Y.; Kume S.; Maegawa H.; Miyake K.; Shojima N.; Yamauchi T.; Yokote K.; Ueki K.; Miyo K.; Ogawa W.

  Journal of Diabetes Investigation, 26 Feb. 2025, Peer-reviewed

  
• Obsessive‐compulsive disorder as an initial manifestation of anti‐glutamic acid decarboxylase antibody‐associated encephalitis

  Naoki Yamahara; Nobuaki Yoshikura; Akio Kimura; Mayu Sakai; Daisuke Yabe; Takayoshi Shimohata

  Neurology and Clinical Neuroscience, 17 May 2024, Peer-reviewed

  
• Whole-exome sequencing in a family with multiple cases of early-onset diabetes reveals a candidate causative mutation in the PTF1A gene

  Daisuke Yabe

  Diabetologia, 2020

  
• Voltage-gated calcium channel α₂δ-1 subunit is involved in the regulation of glucose-stimulated GLP-1 secretion in mice

  Yuhan Yang; Shunsuke Yamane; Norio Harada; Eri Ikeguchi-Ogura; Kana Yamamoto; Naoki Wada; Muhammad Fauzi; Takaaki Murakami; Daisuke Yabe; Yoshitaka Hayashi; Nobuya Inagaki

  American Journal of Physiology-Gastrointestinal and Liver Physiology, 07 Feb. 2025

  
• Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalised for high‐dose corticosteroid therapy: Mitigated iatrogenic hyperglycaemia

  Kaori Ikeda; Fumika Mano‐Usui; Yo Kishimoto; Daisuke Yabe; Nobuya Inagaki; Koichi Omori; Yoji Nagai

  Diabetes, Obesity and Metabolism, 03 Feb. 2025, Peer-reviewed

  
• Chrebp deletion and mild protein restriction additively decrease muscle and bone mass and function.

  Deguchi K.; Ushiroda C.; Hidaka S.; Tsuchida H.; Yamamoto-Wada R.; Seino Y.; Suzuki A.; Yabe D.; Iizuka K.

  Nutrients, Jan. 2025, Peer-reviewed

  
• Effects of tryptophan-selective lipidated glucagon-like peptide 1 (GLP-1) peptides on the GLP-1 receptor

  Xuejing Lu; Norio Harada; Takuma Yasuda; Eri Ikeguchi-Ogura; Daishiro Kobayashi; Masaya Denda; Yohei Seno; Shunsuke Yamane; Daisuke Yabe; Akira Otaka; Nobuya Inagaki

  Journal of Endocrinology, 14 Jan. 2025, Peer-reviewed

  
• Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors

  Ichiro Yamauchi; Daisuke Yabe

  European Thyroid Journal, 10 Jan. 2025, Peer-reviewed, Last author

  
• Adult hypophosphatasia presenting with recurrent acute joint pain

  Hayao Yoshida; Takaaki Murakami; Atsubumi Ogawa; Takashi Sunouchi; Naoko Hidaka; Nobuaki Ito; Hiromi Murakami; Hidenori Kawasaki; Tomoyuki Akiyama; Katsumi Nakajima; Daisuke Yabe; Taizo Yamamoto

  Endocrinology, Diabetes & Metabolism Case Reports, 01 Jan. 2025, Peer-reviewed

  
• Toward a cure for diabetes: iPSC and ESC‐derived islet cell transplantation trials

  Junji Fujikura; Takayuki Anazawa; Taro Toyoda; Ryo Ito; Yasuko Kimura; Daisuke Yabe

  Journal of diabetes investigation, Mar. 2025, Peer-reviewed, Invited, Last author, Corresponding author

  Access this paper :

  
• Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial

  Ildiko Lingvay; Malik Benamar; Liming Chen; Ariel Fu; Esteban Jódar; Tomoyuki Nishida; Jean-Pierre Riveline; Daisuke Yabe; Thomas Zueger; Rosângela Réa

  Diabetologia, 17 Jan. 2025, Peer-reviewed

  
• Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study

  Naoki Wada; Takaaki Murakami; Muhammad Fauzi; Kentaro Sakaki; Shinobu Oshima; Yoshihito Shimada; Kanae Asai; Ayako Oshima; Satoko Nomura; Erina Joo; Michiko Mori; Ryoko Fujiwara; Kenichiro Shide; Keiko Wada; Daisuke Yabe; Nobuya Inagaki; Norio Harada

  Journal of Clinical Medicine Research, Oct. 2024, Peer-reviewed

  
• The Ulaanbaatar agreement: Revising diabetes terminology in Asia to combat stigma

  Yutaka Seino; Daisuke Yabe; Kazuhiro Tsumura; Chien‐Ning Huang; So Hun Kim; Weiping Jia; Altaisaikhan Khasag; Takashi Kadowaki

  Journal of Diabetes Investigation, 03 Oct. 2024, Peer-reviewed

  
• Impaired Fat Absorption from Intestinal Tract in High-Fat Diet Fed Male Mice Deficient in Proglucagon-Derived Peptides

  Koki Nishida; Shinji Ueno; Yusuke Seino; Shihomi Hidaka; Naoya Murao; Yuki Asano; Haruki Fujisawa; Megumi Shibata; Takeshi Takayanagi; Kento Ohbayashi; Yusaku Iwasaki; Katsumi Iizuka; Shoei Okuda; Mamoru Tanaka; Tadashi Fujii; Takumi Tochio; Daisuke Yabe; Yuuichiro Yamada; Yoshihisa Sugimura; Yoshiki Hirooka; Yoshitaka Hayashi; Atsushi Suzuki

  Nutrients, 14 Jul. 2024, Peer-reviewed

  
• Glucagon Stimulation Test and Insulin Secretory Capacity in the Clinical Assessment of Incretin-Based Therapy for Diabetes

  Takuya Haraguchi; Yuji Yamazaki; Hitoshi Kuwata; Ryota Usui; Yoshiyuki Hamamoto; Yutaka Seino; Daisuke Yabe; Yuichiro Yamada

  Diabetes, 28 Aug. 2024, Peer-reviewed

  
• Quality of Life in Japanese People with Type 2 Diabetes Switching from Multiple Daily Insulin Injections to Once-Daily iGlarLixi: SIMPLIFY Japan

  Hitoshi Ishii; Hideki Kamiya; Yoko Takahashi; Yukiko Morimoto; Daisuke Yabe

  Diabetes Therapy, 30 Sep. 2024, Peer-reviewed, Last author

  
• Hypovascular insulinoma with reduced microvessel density on histopathology: a case report

  Risako Imai; Mayu Sakai; Takehiro Kato; Sayako Ozeki; Sodai Kubota; Yanyan Liu; Yoshihiro Takahashi; Ken Takao; Masami Mizuno; Takuo Hirota; Yukio Horikawa; Takaaki Murakami; Tomohiro Kanayama; Takahiro Kuroda; Tatsuhiko Miyazaki; Daisuke Yabe

  Diabetology International, 20 Sep. 2024, Peer-reviewed

  
• Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice

  Yuichiro Yamada; Daisuke Yabe; Kenichiro Shide; Atsushi Suzuki; Yasuo Terauchi; Yasunori Sato; Nobuyuki Shihara; Yutaka Seino

  Journal of Diabetes Investigation, 14 Aug. 2024, Peer-reviewed

  
• PIONEER REAL Japan: Primary results from a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice

  Daisuke Yabe; Yoshiyuki Hamamoto; Daiji Kawanami; Rimei Nishimura; Yasuo Terauchi; Hanan Amadid; Uffe Christian Braae; Atheline Major‐Pedersen; Ryo Suzuki

  Journal of Diabetes Investigation, 22 Aug. 2024, Peer-reviewed, Lead author, Corresponding author

  
• A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes—2nd Edition (English version)

  Ryotaro Bouchi; Tatsuya Kondo; Yasuharu Ohta; Atsushi Goto; Daisuke Tanaka; Hiroaki Satoh; Daisuke Yabe; Rimei Nishimura; Norio Harada; Hideki Kamiya; Ryo Suzuki; Toshimasa Yamauchi; Toshimasa Yamauchi; Ryotaro Bouchi; Tatsuya Kondo; Yasuharu Ohta; Norio Harada; Hideki Kamiy; Toshimasa Yamauchi

  Diabetology International, 11 Jul. 2024, Peer-reviewed

  
• A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes – 2nd edition (English version)

  Ryotaro Bouchi; Tatsuya Kondo; Yasuharu Ohta; Atsushi Goto; Daisuke Tanaka; Hiroaki Satoh; Daisuke Yabe; Rimei Nishimura; Norio Harada; Hideki Kamiya; Ryo Suzuki; Toshimasa Yamauchi

  Journal of Diabetes Investigation, 11 Jul. 2024, Peer-reviewed

  
• Sporadic parathyroid carcinoma treated with lenvatinib, exhibiting a novel somatic MEN1 mutation

  Yu Ito; Toshinori Imaizumi; Hisashi Daido; Takehiro Kato; Daisuke Yabe

  JCEM case reports, 24 Jul. 2024, Peer-reviewed, Last author

  
• A Study on the Compatibility of a Food-Recording Application with Questionnaire-Based Methods in Healthy Japanese Individuals

  Katsumi Iizuka; Kanako Deguchi; Chihiro Ushiroda; Kotone Yanagi; Yusuke Seino; Atsushi Suzuki; Daisuke Yabe; Hitomi Sasaki; Satoshi Sasaki; Eiichi Saitoh; Hiroyuki Naruse

  Nutrients, Jun. 2024

  
• [ ¹⁸ F]FB(ePEG12)12-exendin-4 noninvasive imaging of insulinoma negative for insulin immunostaining on specimen from endoscopic ultrasonography-guided fine needle aspiration: a case report with review of literature

  Daisuke Yabe

  Endocrine journal, May 2024, Peer-reviewed

  
• Harnessing the Therapeutic Potential of SGLT2 Inhibitors in Type 2 Diabetes: Challenges and Opportunities

  Yabe D

  JMA Journal, Apr. 2024, Peer-reviewed, Invited, Lead author, Last author, Corresponding author

  
• PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan

  Ryo Suzuki; Hanan Amadid; Atheline Major‐Pedersen; Daisuke Yabe

  Journal of diabetes investigation, Aug. 2024, Peer-reviewed, Last author

  
• A case of insulinoma misidentified as schizophrenia due to its manifestation in neuropsychiatric symptoms

  Tomoyuki Haba; Kengo Yamakawa; Sayako Ozeki; Akira Sumida; Takehiro Kato; Eiji Kuroda; Takako Maruyama; Takaaki Murakami; Daisuke Yabe

  Diabetology International, Apr. 2024, Peer-reviewed, Last author

  
• GLP-1 受容体作動薬：肥満症の標準治療薬となるか？

  窪田創大; 矢田俊彦; 矢部大介

  肥満研究, Mar. 2024, Invited, Last author, Corresponding author

  
• Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation

  Daisuke Yabe

  Endocrine journal, Feb. 2024, Peer-reviewed

  
• Monogenic Diabetes

  Horikawa Y; HosomichiK; Yabe D

  Diabetology International, Jan. 2024, Peer-reviewed, Invited, Last author

  
• Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan

  Daisuke Yabe; Munehide Matsuhisa; Yoko Takahashi; Yukiko Morimoto; Yasuo Terauchi

  Diabetes therapy, Mar. 2024, Peer-reviewed, Lead author

  
• Visceral adipose tissue quality and its impact on metabolic health

  Sodai Kubota; Daisuke Yabe

  The journal of clinical endocrinology & metabolism, 12 Jul. 2024, Peer-reviewed, Invited, Last author, Corresponding author

  
• Lifestyle factors associated with a rapid decline in the estimated glomerular filtration rate over two years in older adults with type 2 diabetes-Evidence from a large national database in Japan

  Daisuke Yabe

  Plos one, Nov. 2023, Peer-reviewed

  
• Correction: A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes.

  Ryotaro Bouchi; Tatsuya Kondo; Yasuharu Ohta; Atsushi Goto; Daisuke Tanaka; Hiroaki Satoh; Daisuke Yabe; Rimei Nishimura; Norio Harada; Hideki Kamiya; Ryo Suzuki; Toshimasa Yamauchi

  Diabetology international, Oct. 2023

  
• 2型糖尿病の薬物療法のアルゴリズム(第2版)

  坊内 良太郎; 近藤 龍也; 太田 康晴; 後藤 温; 田中 大祐; 佐藤 博亮; 矢部 大介; 西村 理明; 原田 範雄; 神谷 英紀; 鈴木 亮; 山内 敏正; 日本糖尿病学会コンセンサスステートメント策定に関する委員会

  糖尿病, Oct. 2023

  
• Glucokinase variant proteins are resistant to fasting-induced uridine diphosphate glucose-dependent degradation in maturity-onset diabetes of the young type 2 patients

  Jaeyong Cho; Yukio Horikawa; Yuki Oiwa; Kazuyoshi Hosomichi; Daisuke Yabe; Takeshi Imai

  International journal of molecular sciences, 31 Oct. 2023, Peer-reviewed

  
• Long‐term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes

  Yoshihiro Takahashi; Yutaka Seino; Daisuke Yabe

  Journal of diabetes investigation, Jan. 2024, Peer-reviewed, Last author, Corresponding author

  
• Dietary and nutritional guidelines for people with diabetes

  Katsumi Iizuka; Daisuke Yabe

  Nutrients, 10 Oct. 2023, Peer-reviewed, Invited, Last author

  
• Gastric inhibitory polypeptide receptor antagonism suppresses intramuscular adipose tissue accumulation and ameliorates sarcopenia.

  Takahashi Y; Fujita H; Seino Yus; Hattori S; Miyakawa T; Suzuki A; Waki H; Yabe D; Seino Yu; Yamada Y

  Journal of Cachexia, Sarcopenia and Muscle, Dec. 2023, Peer-reviewed

  
• Unmasked insulinoma occasioned by severe hypoglycemic coma immediately postpartum: a case report

  Kiyoshi Matsumoto; Miyu Watanabe; Ken Takao; Hirokazu Takahashi; Hisashi Daido; Toshiro Shibata; Tokuyuki Hirose; Takehiro Kato; Masami Mizuno; Takuo Hirota; Tetsuya Suwa; Yukio Horikawa; Takaaki Murakami; Daisuke Yabe

  BMC Endocrine Disorders, 10 Aug. 2023, Peer-reviewed, Last author

  
• Oral semaglutide under human protocols and doses regulates food intake, body weight, and glycemia in diet-induced obese mice

  Yermek Rakhat; Lei Wang; Wanxin Han; Aktolkyn Rustemova; Nazymgul Kulzhanova; Yuichiro Yamada; Daisuke Yabe; Yutaka Seino; Toshihiko Yada

  Nutrients, Aug. 2023, Peer-reviewed

  
• Effect of roxadustat on thyroid function in patients with renal anemia

  Takuya Haraguchi; Yoshiyuki Hamamoto; Hitoshi Kuwata; Yuji Yamazaki; Susumu Nakatani; Takanori Hyo; Yuichiro Yamada; Daisuke Yabe; Yutaka Seino

  The journal of clinical endocrinology & metabolism, 21 Dec. 2023, Peer-reviewed

  
• Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.

  Vistisen D; Carstensen B; Elisabetta P; Lanzinger S; Tan ECH; Yabe D; Kim DJ; Sheu WHH; Melzer-Cohen C; Holl RW; Núñez J; Ha1 KW; Halvorsen S; Langslet G; Karasik A; Nyström T; Niskanen L; Guleria S; Klement R; Carrasco M; Foersch J; Shay C; Koeneman L; Hoti F; Farsani SF; Khunti K; Zaccardi F; Subramanian A; Nirantharakumar K; EMPRISE EU; East Asia; Study Group

  Cardiovascular Diabetology, Aug. 2023, Peer-reviewed

  
• Efficacy and safety of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, 52‐week clinical trial (EMPA‐ELDERLY)

  Daisuke Yabe; Kosuke Shiki; Gosuke Homma; Thomas Meinicke; Yuji Ogura; Yutaka Seino

  Diabetes, obesity and metabolism, Dec. 2023, Peer-reviewed, Lead author, Corresponding author

  
• Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus

  Shohei Nishida; Takehiro Kato; Yuichi Hayashi; Shoya Yamada; Hironori Fujii; Michi Yamada; Nao Asai; Shinya Shimizu; Takashi Niwa; Hirotoshi Iihara; Sodai Kubota; Mayu Sakai; Yoshihiro Takahashi; Ken Takao; Masami Mizuno; Takuo Hirota; Ryo Kobayashi; Yukio Horikawa; Daisuke Yabe; Akio Suzuki

  Journal of Diabetes Investigation, 25 Jun. 2023, Peer-reviewed

  
• Impact of the angiotensin receptor‐neprilysin inhibitor in clinical diabetes management: Potential benefits and pitfalls

  Tomoko Kato; Takaaki Murakami; Daisuke Yabe; Norio Harada

  Journal of Diabetes Investigation, 25 Jun. 2023, Peer-reviewed

  
• Blockade of glucagon increases muscle mass and alters fiber type composition in mice deficient in proglucagon‐derived peptides

  Shinji Ueno; Yusuke Seino; Shihomi Hidaka; Masashi Nakatani; Keisuke Hitachi; Naoya Murao; Yasuhiro Maeda; Haruki Fujisawa; Megumi Shibata; Takeshi Takayanagi; Katsumi Iizuka; Daisuke Yabe; Yoshihisa Sugimura; Kunihiro Tsuchida; Yoshitaka Hayashi; Atsushi Suzuki

  Journal of Diabetes Investigation, 09 Jun. 2023, Peer-reviewed

  
• Device-supported automated basal insulin titration in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

  Yingying Luo; Yaping Chang; Zhan Zhao; Jun Xia; Chenchen Xu; Yong Mong Bee; Xiaoying Li; Wayne H.-H. Sheu; Margaret McGill; Siew Pheng Chan; Marisa Deodat; Ketut Suastika; Khue Nguyen Thy; Liming Chen; Alice Pik Shan Kong; Wei Chen; Chaicharn Deerochanawong; Daisuke Yabe; Weigang Zhao; Soo Lim; Xiaomei Yao; Linong Ji

  The Lancet Regional Health - Western Pacific, Jun. 2023, Peer-reviewed

  
• Japanese 17q12 deletion syndrome with complex clinical manifestations

  Daisuke Yabe

  Internal medicine, 2024, Peer-reviewed

  
• Use of basal insulin in the management of adults with type 2 diabetes: An Asia‐Pacific evidence‐based clinical practice guideline

  Linong Ji; Yingying Luo; Yong Mong Bee; Jun Xia; Khue Thy Nguyen; Weigang Zhao; Liming Chen; Siew Pheng Chan; Chaicharn Deerochanawong; Soo Lim; Daisuke Yabe; Margaret McGill; Ketut Suastika; Xiaoying Li; Alice Pik Shan Kong; Wei Chen; Zhan Zhao; Chenchen Xu; Marisa Deodat; Xiaomei Yao

  Journal of Diabetes, 23 Apr. 2023, Peer-reviewed

  
• Efficacy and Safety of 6-Month High Dietary Protein Intake in Hospitalized Adults Aged 75 or Older at Nutritional Risk: An Exploratory, Randomized, Controlled Study

  Shota Moyama; Yuichiro Yamada; Noboru Makabe; Hiroki Fujita; Atsushi Araki; Atsushi Suzuki; Yusuke Seino; Kenichiro Shide; Kyoko Kimura; Kenta Murotani; Hiroto Honda; Mariko Kobayashi; Satoshi Fujita; Koichiro Yasuda; Akira Kuroe; Katsushi Tsukiyama; Yutaka Seino; Daisuke Yabe

  Nutrients, 22 Apr. 2023, Peer-reviewed, Last author, Corresponding author

  
• Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta‐analysis

  Yingying Luo; Jun Xia; Zhan Zhao; Yaping Chang; Yong Mong Bee; Khue Thy Nguyen; Soo Lim; Daisuke Yabe; Margaret McGill; Alice Pik Shan Kong; Siew Pheng Chan; Marisa Deodat; Chaicharn Deerochanawong; Ketut Suastika; Chenchen Xu; Liming Chen; Wei Chen; Xiaoying Li; Weigang Zhao; Xiaomei Yao; Linong Ji

  Journal of Diabetes, 10 Apr. 2023, Peer-reviewed

  
• Effect of the Diabetic Nephropathy Aggravation Prevention Program on medical visit behavior in individuals under the municipal national health insurance

  Asuka Ikeda; Makoto Fujii; Yuko Ohno; Kayo Godai; Yaya Li; Yuko Nakamura; Daisuke Yabe; Kazuyo Tsushita; Naoki Kashihara; Kei Kamide; Mai Kabayama

  Journal of Diabetes Investigation, 24 Mar. 2023, Peer-reviewed

  
• Glucose‐dependent insulinotropic polypeptide counteracts diet‐induced obesity along with reduced feeding, elevated plasma leptin and activation of leptin‐responsive and proopiomelanocortin neurons in the arcuate nucleus

  Wanxin Han; Lei Wang; Kento Ohbayashi; Masakazu Takeuchi; Libbey O'Farrell; Tamer Coskun; Yermek Rakhat; Daisuke Yabe; Yusaku Iwasaki; Yutaka Seino; Toshihiko Yada

  Diabetes, Obesity and Metabolism, 28 Feb. 2023, Peer-reviewed

  
• Current status of the rapid decline in renal function due to diabetes mellitus and its associated factors: analysis using the National Database of Health Checkups in Japan

  Makoto Fujii; Yuko Ohno; Asuka Ikeda; Kayo Godai; Yaya Li; Yuko Nakamura; Daisuke Yabe; Kazuyo Tsushita; Naoki Kashihara; Kei Kamide; Mai Kabayama

  Hypertension Research, 02 Feb. 2023, Peer-reviewed

  
• Change of pharmacodynamics parameters following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono sub-study)

  Yabe D; Kawamori D; Seino Yus; Oura T; TakeuchiM

  Diabetes, Obesity and Metabolism, Feb. 2023, Peer-reviewed, Lead author

  
• Empagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in routine care in East Asia: Results from the EMPRISE study

  Dae Jung Kim; Wayne H‐H Sheu; Wook‐Jin Chung; Daisuke Yabe; Kyoung Hwa Ha; Masaomi Nangaku; Elise Chia‐Hui Tan; Koichi Node; Atsutaka Yasui; Weiyu Lei; Sunwoo Lee; Laura Saarelainen; Anouk Deruaz‐Luyet; Moe H Kyaw; Yutaka Seino

  Journal of Diabetes Investigation, 30 Jan. 2023, Peer-reviewed

  
• Two cases of systemic lupus erythematosus after administration of severe acute respiratory syndrome coronavirus 2 vaccine

  Mayu Sakai; Ken Takao; Masami Mizuno; Hironori Ando; Yui Kawashima; Takehiro Kato; Saki Kubota; Tokuyuki Hirose; Takuo Hirota; Yukio Horikawa; Daisuke Yabe

  Modern Rheumatology Case Reports, 27 Jan. 2023, Peer-reviewed, Last author

  
• Editorial: Advances in the research of diabetic nephropathy, volume II

  Daisuke Yabe

  Frontiers in endocrinology, 18 Jan. 2023, Peer-reviewed, Invited

  
• Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study

  Hideaki Miyoshi; Munehide Matsuhisa; Daisuke Yabe; Yoko Takahashi; Yukiko Morimoto; Yasuo Terauchi

  Diabetes therapy, Apr. 2023, Peer-reviewed

  
• Erdheim-chester disease with BRAF V600E mutation and central diabetes insipidus successfully treated with glucocorticoid

  Toshinori Imaizumi; Hisashi Daido; Takehiro Kato; Daisuke Yabe

  JCEM case reports, 17 Feb. 2023, Peer-reviewed, Last author, Corresponding author

  
• Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

  1. KarasikA, Lanzinger S, Tan ECH, Yabe D, Kim DJ, Sheu WHH, Melzer-Cohen C, Holl RW, Ha KH, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K, Nyström T, Niskanen L, Jensen ML, Hoti F, Klement R, Déruaz-Luyet A, Kyaw MH, Koeneman L, Vistisen D, Carstensen B, Halvorsen S, Langslet G, Farsani SF, Patorno E, Núñez J, EMPRISE Europe and Asia Study Group.

  Diabetes & Metabolism, Jan. 2023, Peer-reviewed

  
• Editorial: Advances in the research of diabetic nephropathy

  Daisuke Yabe

  Frontiers in endocrinology, Jan. 2023, Peer-reviewed, Invited

  
• A Consensus Statement from the Japan Diabetes Society (JDS): A Proposed Algorithm for Pharmacotherapy in People with Type 2 Diabetes

  Bouchi R; Kondoh T; Ohta Y; Goto A; Tanaka D; Tanaka H; Yabe D; Nishimura R; Harada N; Kamiya H; Suzuki R; Yamauchi T

  Journal of Diabetes Investigation, Jan. 2023, Peer-reviewed

  
• Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study

  Matsuhisa M; Miyoshi H; Yabe D; Takahashi Y; Morimoto Y; Terauchi Y

  Diabetes Therapy, Jan. 2023, Peer-reviewed

  
• Increased expression of glucagon-like peptide-1 and cystic fibrosis transmembrane conductance regulator in the ileum and colon in mouse treated with metformin

  Momoka Mizoguchi; Hiroshi Takemori; Saho Furukawa; Masafumi Ito; Mutsumi Asai; Hirofumi Morino; Takanori Miura; Daisuke Yabe; Takashi Shibata

  Endocrine Journal, 2023, Peer-reviewed

  
• Advances in insulin therapy from discovery to β‐cell replacement

  Teruaki Sakurai; Sodai Kubota; Takehiro Kato; Daisuke Yabe

  Journal of diabetes investigation, Jan. 2023, Peer-reviewed, Invited, Last author, Corresponding author

  
• A Consensus Statement from the Japan Diabetes Society (JDS): A Proposed Algorithm for Pharmacotherapy in People with Type 2 Diabetes

  Bouchi R; Kondoh T; Ohta Y; Goto A; Tanaka D; Tanaka H; Yabe D; Nishimura R; Harada N; Kamiya H; Suzuki R; Yamauchi T

  Diabetology International, Dec. 2022, Peer-reviewed

  
• Current understanding of imeglimin action on pancreatic β-cells: Involvement of mitochondria and endoplasmic reticulum homeostasis

  Daisuke Yabe

  Journal of diabetes investigation, 2023, Peer-reviewed

  Access this paper :

  
• A novel analysis of intestinal morphology and incretin-producing cells using tissue optical clearing and 3-D imaging.

  Hatoko T; Norio H; Tokumoto S; Yamane S; Ikeguchi-Ogura E; Kato T; Yasuda T; Tatsuoka H; Shimaza-Kuwahara S; Yabe D; Hayashi Y; Inagaki N

  Scientific Reports, Oct. 2022, Peer-reviewed

  Access this paper :

  
• Association of dipeptidyl peptidase-4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan.

  Kubota S; Haraguchi T; Kuwata, H; Seino Y; Murotani K; Tajima T; Terashima, G; Kaneko, M; Takahashi Y; Takao K; Kato T; Shide, K; Imai S; Suzuki A; Terauchi Y; Yamada Y; Seino Y; Yabe D

  Journal of Diabetes Investigation, Sep. 2022, Peer-reviewed, Corresponding author

  
• 2型糖尿病の薬物療法のアルゴリズム

  坊内 良太郎; 近藤 龍也; 太田 康晴; 後藤 温; 田中 大祐; 佐藤 博亮; 矢部 大介; 西村 理明; 原田 範雄; 神谷 英紀; 鈴木 亮; 山内 敏正

  糖尿病, Aug. 2022, Peer-reviewed

  
• Interconnection between cardiovascular, renal, and metabolic disorders: a narrative review with a focus on Japan

  Kadowaki T; Maegawa H; Watada H; Yabe D; Node K; Murohara T; Wada J

  Diabetes, Obesity and Metabolism, Aug. 2022, Peer-reviewed

  
• D-Allulose inhibits ghrelin-responsive, glucose-sensitive and neuropeptide Y neurons in the arcuate nucleus and central injection suppresses appetite-associated food intake in mice

  Rakhat Y; Kaneko K; Wang L; Han W; Seino Y; Yabe D; Yada T

  Nutrients, Jul. 2022, Peer-reviewed

  
• 高齢者糖尿病診療におけるサルコペニアとその予防のための栄養・運動療法

  髙橋佳大; 水野正巳; 矢部大介

  日本体質医学会雑誌, Jul. 2022, Invited, Last author, Corresponding author

  
• SGLT2阻害薬とサルコペニアー期待と課題ー

  窪田創大; 矢部大介

  糖尿病合併症, Jul. 2022, Invited, Last author

  
• The efficacy and safety of once-weekly semaglutide in Japanese subjects with type 2 diabetes by baseline age and body mass index.

  Yabe D; Yamada Y; Kaku K; Nishida T; Sato T; Seino Y

  Journal of Diabetes Investigation, Jul. 2022, Peer-reviewed, Lead author, Corresponding author

  
• Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism.

  Motoko Nomura; Isao Kurihara; Hiroshi Itoh; Takamasa Ichijo; Takuyuki Katabami; Mika Tsuiki; Norio Wada; Takashi Yoneda; Masakatsu Sone; Kenji Oki; Tetsuya Yamada; Hiroki Kobayashi; Kouichi Tamura; Yoshihiro Ogawa; Nobuya Inagaki; Koichi Yamamoto; Michio Otsuki; Daisuke Yabe; Shoichiro Izawa; Yutaka Takahashi; Tomoko Suzuki; Akihiro Yasoda; Akiyo Tanabe; Mitsuhide Naruse

  Hypertension research : official journal of the Japanese Society of Hypertension, 28 Jun. 2022

  
• A case of familial hypocalciuric hypercalcemia type 1 due to CASR p.Pro55Leu mutation.

  Sumida A; Iizuka K; Kato T; Liu Y; Kubota S; Kubota Okamoto S; Sakurai T; Imaizumi T; Takahashi Y; Mizuno M; Takao K; Hirota T; Suwa T; Horikawa Y; Yamamoto M; Seino Y; Suzuki A; Yabe D

  BMC Endocrine Disorders, Jun. 2022, Peer-reviewed, Last author

  
• Semaglutide is effective in type 2 diabetes and obesity with schizophrenia: a case report

  Noda K; Kato T; Nomura N; Sakai M; Kubota S; Hirose T; Liu Y; Takahashi Y; Takao K; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D

  Diabetology International, Jun. 2022, Peer-reviewed, Last author

  
• D-Allulose cooperates with glucagon-like peptide-1 and activates proopiomelanocortin neurons in the arcuate nucleus and central injection inhibits feeding in mice.

  Yermek R; Wang L; Kaneko K; Han W; Seino Y; Yabe D; Yada T

  Biochemical and Biophysical Research Communications., Apr. 2022, Peer-reviewed

  
• Long-term safety and effectiveness of linagliptin by baseline body mass index in Japanese patients with type 2 diabetes: a 3-year post-marketing surveillance study

  Yabe D; Yamamoto F; Lund S; Okamura T; Kadowaki T

  Expert Opinion in Drug Safety, Mar. 2022, Peer-reviewed, Lead author

  
• Unmet needs in current clinical practice for insulinoma: Lessons from nationwide studies in Japan

  Takaaki Murakami; Daisuke Yabe; Nobuya Inagaki

  Journal of diabetes investigation, Mar. 2022, Peer-reviewed

  
• High Protein Diet Feeding Aggravates Hyperaminoacidemia in Mice Deficient in Proglucagon-Derived Peptides.

  Shinji Ueno; Yusuke Seino; Shihomi Hidaka; Ryuya Maekawa; Yuko Takano; Michiyo Yamamoto; Mika Hori; Kana Yokota; Atsushi Masuda; Tatsuhito Himeno; Shin Tsunekawa; Hideki Kamiya; Jiro Nakamura; Hitoshi Kuwata; Haruki Fujisawa; Megumi Shibata; Takeshi Takayanagi; Yoshihisa Sugimura; Daisuke Yabe; Yoshitaka Hayashi; Atsushi Suzuki

  Nutrients, 25 Feb. 2022

  
• Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials.

  Yabe D; Deenadayalan S; Horio H; Kaneto H; Jensen TB; Terauchi Y; Yamada Y; Inagaki N

  Journal of Diabetes Investigation, Jan. 2022, Peer-reviewed, Lead author, Corresponding author

  
• Graves’ disease after administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in a type 1 diabetes patient: a case report

  Sakai M; Takao K; Kato T; Ito K; Kubota S; Hirose T; Liu Y; Mizuno M; Hirota T; Suwa T; Horikawa Y; YabeD

  Internal Medicine, Jan. 2022, Peer-reviewed, Last author

  
• A case of Graves’ disease with thymic hyperplasia: response of thyroid function, thyrotropin receptor autoantibody, and thymic size to thiamazole treatment

  Tsukada D; Iizuka K; Takao K; Liu Y; Kubota So; Okamoto-Kubota S; Sakurai T; Imaizumi T; Sakai M; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yamamoto M; Kubota Su; YabeD

  Internal Medicine, Jan. 2022, Peer-reviewed, Last author

  
• Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism

  Ryo Nakamaru; Koichi Yamamoto; Hiroshi Akasaka; Hiromi Rakugi; Isao Kurihara; Takashi Yoneda; Takamasa Ichijo; Takuyuki Katabami; Mika Tsuiki; Norio Wada; Tetsuya Yamada; Hiroki Kobayashi; Kouichi Tamura; Yoshihiro Ogawa; Junji Kawashima; Nobuya Inagaki; Megumi Fujita; Minemori Watanabe; Kohei Kamemura; Shintaro Okamura; Akiyo Tanabe; Mitsuhide Naruse

  Scientific Reports, Dec. 2021, Peer-reviewed

  
• Healthcare resource utilization in patients treated with empagliflozin in East Asia.

  Sheu WHH; Seino Y; Tan ECH; Yabe D; Ha KH; Nangaku M; Chung WJ; Node K; Yasui A; Lei WY; Lee S; Ustyugova A; Klement R; Deruaz-Luyet A; Kyaw MH; Kim DJ; the EMPRISE East; Asia study group

  Journal of Diabetes Investigation, Dec. 2021, Peer-reviewed

  
• Benefit of insulin glargine/lixisenatide for reducing residual hyperglycaemia in J apan: Post hoc analysis of the LixiLan JP‐O2 trial

  Katsumi Iizuka; Mike Baxter; Daisuke Watanabe; Daisuke Yabe

  Diabetes, Obesity and Metabolism, Dec. 2021, Peer-reviewed, Invited, Last author

  
• Effects of physician’s diabetes self‐management education using Japan Association of Diabetes Education and Care Diabetes Education Card System Program and a self‐monitoring of blood glucose readings analyzer in individuals with type 2 diabetes: An exploratory, open‐labeled, prospective randomized clinical trial

  Nagaaki Tanaka; Daisuke Yabe; Kenta Murotani; Yuko Yamaguchi; Yuki Fujita; Sodai Kubota; Rena Nakashima‐Yasuda; Saki Kubota‐Okamoto; Shinji Ueno; Yuji Yamazaki; Hitoshi Kuwata; Koin Watanabe; Takanori Hyo; Yoshiyuki Hamamoto; Takeshi Kurose; Hiroko Higashiyama; Yusuke Seino; Yuichiro Yamada; Yutaka Seino

  Journal of Diabetes Investigation, Dec. 2021, Peer-reviewed

  
• Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study

  Hitoshi Kuwata; Daisuke Yabe; Kenta Murotani; Yuuka Fujiwara; Takuya Haraguchi; Sodai Kubota; Saki Kubota‐Okamoto; Ryota Usui; Minori Ishitobi; Yuji Yamazaki; Yoshiyuki Hamamoto; Takeshi Kurose; Yusuke Seino; Yuichiro Yamada; Yutaka Seino

  Journal of Diabetes Investigation, Dec. 2021, Peer-reviewed, Corresponding author

  
• Diagnosis and treatment of primary central nervous system lymphoma with the primary lesion in the hypothalamus: a case report

  Ken Takao; Ayaka Tani; Tetsuya Suwa; Yayoi Kuwabara-Ohmura; Kenta Nonomura; Yanyan Liu; Takehiro Kato; Masami Mizuno; Takuo Hirota; Mayumi Enya; Katsumi Iizuka; Yukio Horikawa; Chiemi Saigo; Yusuke Kito; Tatsuhiko Miyazaki; Naoyuki Ohe; Toru Iwama; Daisuke Yabe

  BMC Endocrine Disorders, Dec. 2021, Peer-reviewed, Last author

  
• iGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post‐hoc analysis of the LixiLan JP‐L trial

  Daisuke Yabe; Katsumi Iizuka; Mike Baxter; Daisuke Watanabe; Hideaki Kaneto

  Journal of Diabetes Investigation, Nov. 2021, Peer-reviewed, Lead author, Last author

  
• 【内分泌疾患・糖尿病・代謝疾患-診療のエッセンス】(II章)糖尿病 糖尿病の治療 糖尿病教育・支援とチーム医療

  加藤 丈博; 矢部 大介

  日本医師会雑誌, Oct. 2021

  
• Safety and tolerability of linagliptin in Asians with type 2 diabetes: a pooled analysis of 4457 patients from 21 randomized, double-blind, placebo-controlled clinical trials

  Kanasaki K; Qub S; Yamamoto F; Schepers C; Simõese RS; Yabe D, Ji L

  Expert Opinion in Drug Safety, Oct. 2021, Peer-reviewed

  
• Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: A case report

  Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D

  Endocrine Journal, Oct. 2021, Peer-reviewed, Last author

  
• First Japanese Family with PDX1-MODY (MODY4): A Novel PDX1 Frameshift Mutation, Clinical Features, and Implications

  Yoshiji S; Horikawa Y; Kubota S; Enya M; Iwasaki Y; Keidai Y; Aizawa-Abe M; Iwasaki K; Honjo S; Hosomichi K; Yabe D; Hamasaki A

  Journal of the Endocrine Society, Oct. 2021, Peer-reviewed

  
• Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials

  Yamada Y; Yabe D; Hertz CL; Horio H; Nakamura J; Nielsen AM; Seino Y

  Diabetes, Obesity and Metabolism, Oct. 2021, Peer-reviewed

  
• A novel RFX6 heterozygous mutation (p.R652X) in maturity‐onset diabetes mellitus: A case report

  Sakiho Imaki; Katsumi Iizuka; Yukio Horikawa; Megumi Yasuda; Sodai Kubota; Takehiro Kato; Yanyan Liu; Ken Takao; Masami Mizuno; Takuo Hirota; Tetsuya Suwa; Kazuyoshi Hosomichi; Atsushi Tajima; Yuuka Fujiwara; Yuji Yamazaki; Hitoshi Kuwata; Yutaka Seino; Daisuke Yabe

  Journal of Diabetes Investigation, Oct. 2021, Peer-reviewed, Last author

  
• Elevation of Fasting GLP-1 Levels in Child and Adolescent Obesity: Friend or Foe?

  Sodai Kubota; Daisuke Yabe

  The Journal of Clinical Endocrinology & Metabolism, 18 Aug. 2021, Peer-reviewed, Invited, Last author, Corresponding author

  
• Voxel‐based specific regional analysis system for Alzheimer’s disease utility as a screening tool for unrecognized cognitive dysfunction of elderly patients in diabetes outpatient clinics: Multicenter retrospective exploratory study

  Yoko Ueba; Takaaki Murakami; Taizo Yamamoto; Akira Kuroe; Masahide Yamasaki; Daita Kaneda; Daisuke Otani; Sakura Kiyobayashi; Kaori Ikeda; Daisuke Yabe; Masahito Ogura; Nobuya Inagaki

  Journal of Diabetes Investigation, 17 Jul. 2021

  
• VSRAD utility as a screening tool for unrecognized cognitive dysfunction of elderly patients in diabetic outpatient clinics: Multi-center retrospective exploratory study.

  Ueba Y; Murakami T; Yamamoto T; Kuroe A; Yamasaki M; Kaneda D; Otani D; Kiyobayashi S; Ikeda K; Yabe D; Ogura M; Inagaki N

  Journal of Diabetes Investigation, Jun. 2021, Peer-reviewed

  
• Hypoglycemic coma in an elderly adult switched from twice-daily vildagliptin to once-daily glimepiride to improve drug adherence

  Shunsuke Tominari; Megumi Yasuda; Takehiro Kato; Mayu Sakai; Sodai Kubota; Kenta Nonomura; Tokuyuki Hirose; Ken Takao; Yanyan Liu; Masami Mizuno; Takuo Hirota; Katsumi Iizuka; Tetsuya Suwa; Yukio Horikawa; Daisuke Yabe

  Diabetology International, 05 May 2021, Last author

  
• Effect of hypertriglyceridemia in dyslipidemia‐induced impaired glucose tolerance and sex differences in dietary features associated with hypertriglyceridemia among the Japanese population: The Gifu Diabetes Study

  Yukiko Nonoyama; Mayumi Yamamoto; Shino Oba; Yukio Horikawa; Chisato Nagata; Daisuke Yabe; Jun Takeda

  Journal of Diabetes Investigation, May 2021, Peer-reviewed

  
• Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium–glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes

  Daisuke Yabe; Kosuke Shiki; Keiko Suzaki; Thomas Meinicke; Yutaro Kotobuki; Kenichiro Nishida; Douglas Clark; Atsutaka Yasui; Yutaka Seino

  BMJ Open, Apr. 2021, Peer-reviewed, Lead author, Last author, Corresponding author

  
• Carbonic anhydrase 8 (CAR8) negatively regulates GLP-1 secretion from enteroendocrine cells in response to long-chain fatty acids

  Yuta Fujiwara; Shunsuke Yamane; Norio Harada; Eri Ikeguchi-Ogura; Ryota Usui; Toshihiro Nakamura; Kanako Iwasaki; Kazuyo Suzuki; Daisuke Yabe; Yoshitaka Hayashi; Nobuya Inagaki

  American Journal of Physiology-Gastrointestinal and Liver Physiology, 01 Apr. 2021, Peer-reviewed

  
• Effects of ChREBP deficiency on adrenal lipogenesis and steroidogenesis

  Ken Takao; Katsumi Iizuka; Yanyan Liu; Teruaki Sakurai; Sodai Kubota; Saki Kubota-Okamoto; Toshinori Imaizumi; Yoshihiro Takahashi; Yermek Rakhat; Satoko Komori; Tokuyuki Hirose; Kenta Nonomura; Takehiro Kato; Masami Mizuno; Tetsuya Suwa; Yukio Horikawa; Masakatsu Sone; Daisuke Yabe

  Journal of Endocrinology, Mar. 2021, Peer-reviewed, Last author

  
• Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study

  Yutaka Seino; Dae Jung Kim; Daisuke Yabe; Elise Chia‐Hui Tan; Wook‐Jin Chung; Kyoung Hwa Ha; Masaomi Nangaku; Koichi Node; Riho Klement; Atsutaka Yasui; Wei‐Yu Lei; Sunwoo Lee; Moe H. Kyaw; Anouk Deruaz‐Luyet; Kimberly G. Brodovicz; Wayne H.‐H. Sheu

  Endocrinology, Diabetes & Metabolism, Jan. 2021, Peer-reviewed

  
• Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial

  Takashi Kadowaki; Guang Wang; Julio Rosenstock; Daisuke Yabe; Yongde Peng; Keizo Kanasaki; Yiming Mu; Michaela Mattheus; Annett Keller; Tomoo Okamura; Odd Erik Johansen; Nikolaus Marx

  Diabetology International, Jan. 2021, Peer-reviewed

  
• ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue

  Katsumi Iizuka; Ken Takao; Daisuke Yabe

  Frontiers in Endocrinology, 03 Dec. 2020, Peer-reviewed, Invited, Last author

  
• The Smart Life Stay (SLS) program: effects of a lifestyle intervention program in combination with health tourism and health guidance for type 2 diabetes

  Madoka Matsushita; Akiko Muramoto; Eri Nomura; Yukari Eguchi; Ayako Kato; Yoshiko Sano; Mai Kabayama; Masashi Arakawa; Yuko Oguma; Daisuke Yabe; Masaaki Matsunaga; Hiroshi Yatsuya; Hiroshi Arima; Kazuyo Tsushita

  Nutrition & Diabetes, Dec. 2020, Peer-reviewed

  
• Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan

  Daisuke Yabe; Hiroko Higashiyama; Takashi Kadowaki; Hideki Origasa; Iichiro Shimomura; Hirotaka Watada; Keisuke Tobe; Kristy Iglay; Shigeru Tokita; Yutaka Seino

  BMJ Open Diabetes Research & Care, Nov. 2020, Peer-reviewed

  
• Generation and Characterization of a Novel Mouse Model That Allows Spatiotemporal Quantification of Pancreatic β-Cell Proliferation

  Shinsuke Tokumoto; Daisuke Yabe; Hisato Tatsuoka; Ryota Usui; Muhammad Fauzi; Ainur Botagarova; Hisanori Goto; Pedro Luis Herrera; Masahito Ogura; Nobuya Inagaki

  Diabetes, 01 Nov. 2020, Peer-reviewed

  
• Cardioprotective effects of GLP‐1(28‐36a): A degraded metabolite or GLP‐1’s better half?

  Yangyang Liu; Sodai Kubota; Katsumi Iizuka; Daisuke Yabe

  Journal of Diabetes Investigation, Nov. 2020, Peer-reviewed, Invited, Last author, Corresponding author

  
• Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects

  Takaaki Murakami; Hiroyuki Fujimoto; Naotaka Fujita; Keita Hamamatsu; Daisuke Yabe; Nobuya Inagaki

  Journal of Diabetes Investigation, Nov. 2020, Peer-reviewed

  
• Tumor‐like features of gene expression and metabolic profiles in enlarged pancreatic islets are associated with impaired incretin‐induced insulin secretion in obese diabetes: A study of Zucker fatty diabetes mellitus rat

  Tomohide Hayami; Norihide Yokoi; Takuro Yamaguchi; Kohei Honda; Naoya Murao; Harumi Takahashi; Shujie Wang; Yusuke Seino; Hideki Kamiya; Daisuke Yabe; Ian R Sweet; Akira Mizoguchi; Jiro Nakamura; Susumu Seino

  Journal of Diabetes Investigation, Nov. 2020, Peer-reviewed

  
• Single-cell Transcriptome Analysis Dissects the Replicating Process of Pancreatic Beta Cells in Partial Pancreatectomy Model.

  Tatsuoka H; Sakamoto S; Yabe D; Kabai R; Kato U; Okumura T; Botagarova A; Tokumoto S; Usui R; Ogura M; Nagashima K; Mukai E; Fujitani Y; Watanabe A; Inagaki N

  iScience, Oct. 2020, Peer-reviewed

  
• Low-dose Selective Arterial Calcium Stimulation Test for Localizing Insulinoma: A Single-center Experience of Five Consecutive Cases

  Tomonobu Hatoko; Takaaki Murakami; Masakatsu Sone; Daisuke Yabe; Toshihiko Masui; Yuji Nakamoto; Akihiro Furuta; Norimitsu Uza; Yuzo Kodama; Norio Harada; Masahito Ogura; Akihiro Yasoda; Nobuya Inagaki

  Internal Medicine, 01 Oct. 2020, Peer-reviewed

  
• Rb and p53 Execute Distinct Roles in the Development of Pancreatic Neuroendocrine Tumors

  Yuki Yamauchi; Yuzo Kodama; Masahiro Shiokawa; Nobuyuki Kakiuchi; Saiko Marui; Takeshi Kuwada; Yuko Sogabe; Teruko Tomono; Atsushi Mima; Toshihiro Morita; Tomoaki Matsumori; Tatsuki Ueda; Motoyuki Tsuda; Yoshihiro Nishikawa; Katsutoshi Kuriyama; Yojiro Sakuma; Yuji Ota; Takahisa Maruno; Norimitsu Uza; Atsuhiro Masuda; Hisato Tatsuoka; Daisuke Yabe; Sachiko Minamiguchi; Toshihiko Masui; Nobuya Inagaki; Shinji Uemoto; Tsutomu Chiba; Hiroshi Seno

  Cancer Research, 01 Sep. 2020, Peer-reviewed

  
• The Asian Association for the Study of Diabetes: The first 10 years and the next 10 years

  Yutaka Seino; Yuji Yamazaki; Daisuke Yabe

  Journal of Diabetes Investigation, Sep. 2020, Peer-reviewed, Last author

  
• Benefits of the fixed‐ratio combination of insulin glargine 100 units/mL and lixisenatide (iGlarLixi) in Japanese people with type 2 diabetes: A subgroup and time‐to‐control analysis of the LixiLan JP phase 3 trials

  Yasuo Terauchi; Daisuke Yabe; Hideaki Kaneto; Atsushi Amano; Mike Baxter; Daisuke Watanabe; Hirotaka Watada; Nobuya Inagaki

  Diabetes, Obesity and Metabolism, Sep. 2020, Peer-reviewed

  
• Rb and p53 Execute Distinct Roles in the Development of Pancreatic Neuroendocrine Tumors

  Yuki Yamauchi; Yuzo Kodama; Masahiro Shiokawa; Nobuyuki Kakiuchi; Saiko Marui; Takeshi Kuwada; Yuko Sogabe; Teruko Tomono; Atsushi Mima; Toshihiro Morita; Tomoaki Matsumori; Tatsuki Ueda; Motoyuki Tsuda; Yoshihiro Nishikawa; Katsutoshi Kuriyama; Yojiro Sakuma; Yuji Ota; Takahisa Maruno; Norimitsu Uza; Atsuhiro Masuda; Hisato Tatsuoka; Daisuke Yabe; Sachiko Minamiguchi; Toshihiko Masui; Nobuya Inagaki; Shinji Uemoto; Tsutomu Chiba; Hiroshi Seno

  Cancer Research, 01 Sep. 2020, Peer-reviewed

  
• Alcohol‐induced impaired insulin secretion in a Japanese population: 5‐year follow up in the Gifu Diabetes Study

  Natsumi Ueda; Mayumi Yamamoto; Mitsuhiro Nakamura; Yumi Motooka; Yoko Nakayama; Yukiko Nonoyama; Shino Oba; Yukio Horikawa; Chisato Nagata; Daisuke Yabe; Kayoko Adachi; Mitsuyo Araki; Kenzo Chimori; Hisashi Daidoh; Katumasa Fushimi; Eiichi Goshima; Hideo Hayashi; Makoto Hayashi; Tatsuyuki Imai; Maho Ishii; Midori Izai; Keita Kamikubo; Yoshinori Kanoh; Masahisa Kitada; Noriko Kojima; Toshihiro Kojima; Takuji Komaki; Joji Kosaka; Hiroyuki Maekawa; Masanori Murayama; Masafumi Matsuda; Ikuo Matsui; Yoshikazu Morimoto; Yasuo Morioka; Hiroshi Murase; Kotaro Nagai; Toshihiko Nagashima; Nobuteru Noda; Nobuyasu Noritake; Kazuhiro Ohmae; Shigehiko Ozeki; Shigeki Sakata; Hiroshi Sarui; Mayumi Sato; Miyuki Sugimoto; Eiji Suzuki; Noriyuki Takeda; Rieko Totani; Takaaki Wada; Yuji Wada; Michie Yokoyama; Kouji Yoshino

  Journal of Diabetes Investigation, Sep. 2020, Peer-reviewed

  
• The Smart Life Stay (SLS) program: effects of a lifestyle intervention program in combination with health tourism and health guidance for type 2 diabetes.

  Madoka Matsushita; Akiko Muramoto; Eri Nomura; Yukari Eguchi; Ayako Kato; Yoshiko Sano; Mai Kabayama; Masashi Arakawa; Yuko Oguma; Daisuke Yabe; Masaaki Matsunaga; Hiroshi Yatsuya; Hiroshi Arima; Kazuyo Tsushita

  Nutrition & diabetes, 29 Aug. 2020, Peer-reviewed

  
• Diabetes and COVID-19: IDF perspective in the Western Pacific region.

  Yerin Hwang; Altaisaikhan Khasag; Weiping Jia; Alicia Jenkins; Chien-Ning Huang; Daisuke Yabe; Doo-Man Kim; Takashi Kadowaki; Moon-Kyu Lee

  Diabetes research and clinical practice, Aug. 2020

  
• A review of recent findings on meal sequence: an attractive dietary approach to prevention and management of type 2 diabetes

  Sodai K; Liu Y; Iizuka K; Kuwata H; Seino Y; Yabe D

  Nutrients, Aug. 2020, Peer-reviewed, Last author, Corresponding author

  
• Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA® Trial

  Hirotaka Watada; Hiroyuki Sakamaki; Daisuke Yabe; Fumiko Yamamoto; Tatsunori Murata; Keigo Hanada; Tetsuaki Hirase; Tomoo Okamura

  Diabetes Therapy, Aug. 2020, Peer-reviewed

  
• A case of MODY5-like manifestations without mutations or deletions in coding and minimal promoter regions of the HNF1B gene

  Yayoi Kuwabara-Ohmura; Katsumi Iizuka; Yanyan Liu; Ken Takao; Kenta Nonomura; Takehiro Kato; Masami Mizuno; Kazuyoshi Hosomichi; Atsushi Tajima; Tatsuhiko Miyazaki; Yukio Horikawa; Daisuke Yabe

  Endocrine Journal, Aug. 2020, Peer-reviewed, Last author

  
• SGLT2 Inhibitor and GLP-1 Receptor Agonist Combination Therapy Substantially Improved the Renal Function in a Patient with Type 2 Diabetes: Implications for Additive Renoprotective Effects of the Two Drug Classes

  Kenta Nonomura; Katsumi Iizuka; Yayoi Kuwabara-Ohmura; Daisuke Yabe

  Internal Medicine, 15 Jun. 2020, Peer-reviewed, Last author

  
• The Role of Metagenomics in Precision Nutrition

  Katsumi Iizuka; Daisuke Yabe

  Nutrients, 04 Jun. 2020, Peer-reviewed, Last author

  
• Ceritinib‐associated hyperglycemia in the Japanese Adverse Drug Event Report Database

  Haruka Fujita; Takaaki Murakami; Fumiaki Tomoike; Daisuke Yabe; Nobuya Inagaki

  Journal of Diabetes Investigation, May 2020, Peer-reviewed

  
• Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

  Daisuke Yabe; Jiro Nakamura; Hideaki Kaneto; Srikanth Deenadayalan; Andrea Navarria; Mette Gislum; Nobuya Inagaki; T Arisaka; T Asakura; N Azuma; S Fukuda; Y Fukushima; N Harada; S Inoue; H Ishida; H Ishii; S Ishikawa; H Jinnouchi; S Kaneko; K Kanno; M Kato; Y Kato; T Kawada; H Kim; A Kiyosue; O Matsuoka; O Miho; S Nakamoto; S Nakamura; S Nakanishi; H Nishimura; A Numata; T Ohama; T Okabe; F Okuguchi; T Osonoi; T Sasaki; H Seino; K Shin; T Shiraiwa; T Sugiura; S Wada; A Yamauchi

  The Lancet Diabetes & Endocrinology, May 2020, Peer-reviewed, Lead author, Corresponding author

  
• Utility of microcatheter in adrenal venous sampling for primary aldosteronism

  Yoshifumi Noda; Satoshi Goshima; Shoma Nagata; Hiroshi Kawada; Yukichi Tanahashi; Takehiro Kato; Tetsuya Suwa; Nobuyuki Kawai; Daisuke Yabe; Masayuki Matsuo

  The British Journal of Radiology, 01 May 2020

  
• Sodium–glucose cotransporter 2 inhibitor and sarcopenia in a lean elderly adult with type 2 diabetes: A case report

  Megumi Yasuda; Katsumi Iizuka; Takehiro Kato; Yanyan Liu; Ken Takao; Kenta Nonomura; Masami Mizuno; Daisuke Yabe

  Journal of Diabetes Investigation, May 2020, Peer-reviewed, Last author

  
• Correction to: Japanese Clinical Practice Guideline for Diabetes 2016.

  Masakazu Haneda; Mitsuhiko Noda; Hideki Origasa; Hiroshi Noto; Daisuke Yabe; Yukihiro Fujita; Atsushi Goto; Tatsuya Kondo; Eiichi Araki

  Diabetology international, Apr. 2020, Peer-reviewed

  
• Factory-calibrated continuous glucose monitoring and capillary blood glucose monitoring in a case with insulinoma: usefulness and possible pitfall under chronic hyperinsulinemic hypoglycemia.

  Keiichiro Suminaga; Takaaki Murakami; Daisuke Yabe; Masakatsu Sone; Taku Sugawa; Toshihiko Masui; Norimitsu Uza; Akihiko Yoshizawa; Masahito Ogura; Akihiro Yasoda; Nobuya Inagaki

  Endocrine journal, 28 Mar. 2020, Peer-reviewed

  
• Dietary instructions focusing on meal-sequence and nutritional balance for prediabetes subjects: An exploratory, cluster-randomized, prospective, open-label, clinical trial.

  Daisuke Yabe; Hitoshi Kuwata; Yuuka Fujiwara; Mayuka Sakaguchi; Shota Moyama; Noboru Makabe; Kenta Murotani; Hiroshi Asano; Sanae Ito; Hideyuki Mishima; Hideto Takase; Noriyasu Ota; Yusuke Seino; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino

  Journal of diabetes and its complications, Dec. 2019, Peer-reviewed

  Access this paper :

  
• GPR40 activation initiates store-operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells.

  Ryota Usui; Daisuke Yabe; Muhammad Fauzi; Hisanori Goto; Ainur Botagarova; Shinsuke Tokumoto; Hisato Tatsuoka; Yumiko Tahara; Shizuka Kobayashi; Toshiya Manabe; Yoshihiro Baba; Tomohiro Kurosaki; Pedro Luis Herrera; Masahito Ogura; Kazuaki Nagashima; Nobuya Inagaki

  Scientific reports, 29 Oct. 2019, Peer-reviewed

  Access this paper :

  
• The journey to understanding incretin systems: Theory, practice and more theory.

  Daisuke Yabe; Hitoshi Kuwata; Yutaka Seino

  Journal of diabetes investigation, Sep. 2019

  
• Bullous pemphigoid with dipeptidyl peptidase‐4 inhibitors: Clinical features and pathophysiology

  Takaaki Murakami; Daisuke Yabe; Nobuya Inagaki

  Journal of Diabetes Investigation, Sep. 2019, Peer-reviewed

  
• Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia

  Seino Y; Ueno S; Yabe D; Suzuki A

  Journal of Diabetes Investigation, Aug. 2019, Peer-reviewed, Invited

  
• Low-carbohydrate diet by staple change attenuates postprandial GIP and CPR levels in type 2 diabetes patients

  Kondo-Ando M; Seino Y; Morikawa R; Negi K; Todoroki H; Kawakami T; Asada Y; Yoshimoto R; Tanaka C; Okamoto K; Masuda A; Tomatsu E; Hiratsuka I; Yoshino Y; Maki W; Kakita A; Shibata M; Takayanagi T; Makino M; Sugimura Y; Asai S; Ito A; Ueno S; Fujiwara Y; Kuwata H; Yabe D; Suzuki A

  Journal of Diabetes and Its Complications, Aug. 2019, Peer-reviewed

  
• A journey to understanding incretin systems: theory, practice, and more theory

  Yabe D; Kuwata H; Seino Y

  Journal of Diabetes Investigation, Jul. 2019, Peer-reviewed, Invited

  
• Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity

  Ryota Usui; Daisuke Yabe; Yutaka Seino

  Journal of Diabetes Investigation, Jul. 2019, Peer-reviewed, Invited, Corresponding author

  
• A rare case of autoimmune polyglandular syndrome with Sjögren's syndrome and primary hypoparathyroidism.

  Katsumi Iizuka; Masami Mizuno; Kenta Nonomura; Daisuke Yabe

  BMJ case reports, 27 May 2019, Peer-reviewed

  
• Sphingosine kinase 1–interacting protein is a dual regulator of insulin and incretin secretion

  Yanyan Liu; Shin‐Ichi Harashima; Yu Wang; Kazuyo Suzuki; Shinsuke Tokumoto; Ryota Usui; Hisato Tatsuoka; Daisuke Tanaka; Daisuke Yabe; Norio Harada; Yoshitaka Hayashi; Nobuya Inagaki

  The FASEB Journal, May 2019, Peer-reviewed

  
• Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trials

  Daisuke Yabe; Atsutaka Yasui; Linong Ji; Moon-Kyu Lee; Ronald Ching Wan Ma; Tien-Jyun Chang; Tomoo Okamura; Cordula Zeller; Stefan Kaspers; Jisoo Lee; Sven Kohler; Yutaka Seino

  Journal of Diabetes Investigation, Mar. 2019, Peer-reviewed, Lead author

  Access this paper :

  
• Case 23-2018: A Man with Episodes of Confusion and Hypoglycemia

  Murakami T; Yabe D; Inagaki N

  New England Journal of Medicine, Nov. 2018, Peer-reviewed

  
• Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes.

  Hitoshi Kuwata; Saki Okamoto; Yusuke Seino; Kenta Murotani; Hisato Tatsuoka; Ryota Usui; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino; Daisuke Yabe

  Journal of diabetes investigation, Sep. 2018, Peer-reviewed

  
• Mental distress and health-related quality of life among type 1 and type 2 diabetes patients using self-monitoring of blood glucose: A cross-sectional questionnaire study in Japan.

  Nagaaki Tanaka; Daisuke Yabe; Kenta Murotani; Shinji Ueno; Hitoshi Kuwata; Yoshiyuki Hamamoto; Takeshi Kurose; Nobuo Takahashi; Tomoyuki Akashi; Takashi Matsuoka; Takeshi Osonoi; Masae Minami; Dai Shimono; Yutaka Seino

  Journal of diabetes investigation, Sep. 2018, Peer-reviewed

  
• Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes.

  Hitoshi Kuwata; Saki Okamoto; Yusuke Seino; Kenta Murotani; Hisato Tatsuoka; Ryota Usui; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino; Daisuke Yabe

  Journal of diabetes investigation, Sep. 2018, Peer-reviewed

  
• Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.

  Ryota Usui; Yui Sakuramachi; Yusuke Seino; Kenta Murotani; Hitoshi Kuwata; Hisato Tatsuoka; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino; Daisuke Yabe

  Journal of diabetes investigation, Jul. 2018, Peer-reviewed

  Access this paper :

  
• Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation.

  Ryota Usui; Yui Sakuramachi; Yusuke Seino; Kenta Murotani; Hitoshi Kuwata; Hisato Tatsuoka; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino; Daisuke Yabe

  Journal of diabetes investigation, Jul. 2018, Peer-reviewed

  Access this paper :

  
• Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.

  Ryota Usui; Yui Sakuramachi; Yusuke Seino; Kenta Murotani; Hitoshi Kuwata; Hisato Tatsuoka; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino; Daisuke Yabe

  Journal of diabetes investigation, Jul. 2018, Peer-reviewed

  Access this paper :

  
• Japanese Clinical Practice Guideline for Diabetes 2016

  Masakazu Haneda; Mitsuhiko Noda; Hideki Origasa; Hiroshi Noto; Daisuke Yabe; Yukihiro Fujita; Atsushi Goto; Tatsuya Kondo; Eiichi Araki

  Journal of Diabetes Investigation, 01 May 2018, Peer-reviewed, Invited

  Access this paper :

  
• Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases.

  Satoshi Yoshiji; Takaaki Murakami; Shin-Ichi Harashima; Rie Ko; Riko Kashima; Daisuke Yabe; Masahito Ogura; Kentaro Doi; Nobuya Inagaki

  Journal of diabetes investigation, Mar. 2018, Peer-reviewed

  Access this paper :

  
• Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label, single-arm study

  Yutaka Seino; Daisuke Yabe; Takashi Sasaki; Atsushi Fukatsu; Hisae Imazeki; Hidekazu Ochiai; Soichi Sakai

  Journal of Diabetes Investigation, 01 Mar. 2018, Peer-reviewed

  
• Japanese Clinical Practice Guideline for Diabetes 2016

  Masakazu Haneda; Mitsuhiko Noda; Hideki Origasa; Hiroshi Noto; Daisuke Yabe; Yukihiro Fujita; Atsushi Goto; Tatsuya Kondo; Eiichi Araki

  Diabetology International, 01 Feb. 2018, Peer-reviewed

  
• 体質医学からみた日本人２型糖尿病の病態とインクレチンによる治療戦略

  矢部大介

  日本体質医学会雑誌, Feb. 2018, Invited

  
• Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes

  Yutaka Seino; Yasuo Terauchi; Takeshi Osonoi; Daisuke Yabe; Nobuyuki Abe; Tomoyuki Nishida; Jeppe Zacho; Shizuka Kaneko

  Diabetes, Obesity and Metabolism, 01 Feb. 2018, Peer-reviewed

  Access this paper :

  
• Hypoglycemia unawareness in insulinoma revealed with flash glucose monitoring systems

  Taku Sugawa; Takaaki Murakami; Daisuke Yabe; Riko Kashima; Makiko Tatsumi; Shinobu Ooshima; Erina Joo; Keiko Wada; Atsushi Yoshizawa; Toshihiko Masui; Yuji Nakamoto; Yuki Yamauchi; Yuzo Kodama; Yoshiki Iemura; Masahito Ogura; Akihiro Yasoda; Nobuya Inagaki

  Internal Medicine, 2018, Peer-reviewed

  
• A novel ultrasonography measurement of internal carotid artery stenosis: Comparison with the North American Symptomatic Carotid Endarterectomy Trial angiographic method

  Etoh H; Takasaki M; Sato H; Teramura S; Shimizu S; Yabe D; Fujimoto Y; Seino Y

  Neurosonology, Jan. 2018, Peer-reviewed

  
• Incretin concept revised: The origin of the insulinotropic function of glucagon-like peptide-1 – the gut, the islets or both?

  Daisuke Yabe; Yusuke Seino; Yutaka Seino

  Journal of Diabetes Investigation, 01 Jan. 2018, Peer-reviewed, Invited

  Access this paper :

  
• Classification of GLP-1 Receptor Agonists by Their Modes of Action

  Daisuke Yabe

  Journal of the Japan Diabetes Society, Oct. 2017, Peer-reviewed, Invited

  
• Beta cell replacement strategies for diabetes.

  Kieffer TJ; Woltjen K; Osafune K; Yabe D; Inagaki N

  J Diabetes Investig, Oct. 2017, Peer-reviewed, Invited

  
• GLP-１受容体作動薬による糖尿病合併症抑制

  矢部大介

  内分泌・糖尿病・代謝内科, Aug. 2017, Invited

  
• Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged >= 60 years (START-J trial)

  Yasuo Terauchi; Yuichiro Yamada; Hitoshi Ishida; Mitsuru Ohsugi; Masafumi Kitaoka; Jo Satoh; Daisuke Yabe; Nobuyuki Shihara; Yutaka Seino

  DIABETES OBESITY & METABOLISM, Aug. 2017, Peer-reviewed

  
• Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study

  Daisuke Yabe; Masahiro Iwasaki; Hitoshi Kuwata; Takuya Haraguchi; Yoshiyuki Hamamoto; Takeshi Kurose; Kiminobu Sumita; Hitoshi Yamazato; Shigeto Kanada; Yutaka Seino

  DIABETES OBESITY & METABOLISM, May 2017, Peer-reviewed

  
• Cardiovascular safety trials of incretin-based drugs: What do they mean?

  Daisuke Yabe; Yutaka Seino

  JOURNAL OF DIABETES INVESTIGATION, May 2017, Peer-reviewed, Invited

  Access this paper :

  
• Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open-label, 2-arm parallel comparative, exploratory trial

  Daisuke Yabe; Takashi Eto; Masanari Shiramoto; Shin Irie; Kenta Murotani; Yusuke Seino; Hitoshi Kuwata; Takeshi Kurose; Susumu Seino; Bo Ahren; Yutaka Seino

  DIABETES OBESITY & METABOLISM, Mar. 2017, Peer-reviewed

  
• Sodium glucose co-transporter 2 inhibitor luseogliflozin in the management of type 2 diabetes: a drug safety evaluation

  Daisuke Yabe; Yoshiyuki Hamamoto; Yusuke Seino; Hitoshi Kuwata; Takeshi Kurose; Yutaka Seino

  EXPERT OPINION ON DRUG SAFETY, 2017, Peer-reviewed, Invited

  
• 日本糖尿病協会の糖尿病教育・支援ツールを活かす～質の高い療養指導の均てん化に向けて～

  矢部大介; 清野裕

  糖尿病合併症, Jan. 2017, Invited

  
• Insulinoma with a History of Epilepsy: Still a Possible Misleading Factor in the Early Diagnosis of Insulinoma

  Takaaki Murakami; Takafumi Yamashita; Daisuke Yabe; Toshihiko Masui; Yuki Teramoto; Sachiko Minamiguchi; Keisho Hirota; Masahito Ogura; Kazuaki Nagashima; Nobuya Inagaki

  INTERNAL MEDICINE, 2017, Peer-reviewed

  
• Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse beta-cell function in the GetGoal-M and GetGoal-S trials

  Daisuke Yabe; Anu Ambos; Bertrand Cariou; Lea Duvnjak; Marc Evans; Guillermo Gonzalez-Galvez; Jay Lin; Elena V. Nikonova; Pedro de Pablos-Velasco; Jean-Francois Yale; Bo Ahren

  JOURNAL OF DIABETES AND ITS COMPLICATIONS, Sep. 2016, Peer-reviewed

  
• Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin

  Atsushi Iida; Yusuke Seino; Ayako Fukami; Ryuya Maekawa; Daisuke Yabe; Shinobu Shimizu; Keita Kinoshita; Yusuke Takagi; Takako Izumoto; Hidetada Ogata; Kota Ishikawa; Nobuaki Ozaki; Shin Tsunekawa; Yoji Hamada; Yutaka Oiso; Hiroshi Arima; Yoshitaka Hayashi

  DIABETOLOGIA, Jul. 2016, Peer-reviewed

  
• Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin.

  Atsushi Iida; Yusuke Seino; Ayako Fukami; Ryuya Maekawa; Daisuke Yabe; Shinobu Shimizu; Keita Kinoshita; Yusuke Takagi; Takako Izumoto; Hidetada Ogata; Kota Ishikawa; Nobuaki Ozaki; Shin Tsunekawa; Yoji Hamada; Yutaka Oiso; Hiroshi Arima; Yoshitaka Hayashi

  Diabetologia, 06 Apr. 2016, Peer-reviewed

  
• Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives

  Yutaka Seino; Hitoshi Kuwata; Daisuke Yabe

  JOURNAL OF DIABETES INVESTIGATION, Apr. 2016, Peer-reviewed

  
• Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial

  Hitoshi Kuwata; Masahiro Iwasaki; Shinobu Shimizu; Kohtaro Minami; Haruyo Maeda; Susumu Seino; Koji Nakada; Chihiro Nosaka; Kenta Murotani; Takeshi Kurose; Yutaka Seino; Daisuke Yabe

  DIABETOLOGIA, Mar. 2016, Peer-reviewed

  
• Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation

  Daisuke Yabe; Yutaka Seino

  EXPERT OPINION ON DRUG SAFETY, Feb. 2016, Peer-reviewed, Invited

  
• SGLT2阻害薬：副作用の観点から

  矢部大介; 桑田仁司; 清野裕

  糖尿病合併症, 2016, Invited

  
• Meal sequence and glucose excursion

  Yabe Daisuke; Kuwata Hitoshi; Seino Yutaka

  Journal of the Japan Diabetes Society, 2016, Peer-reviewed

  
• Type 2 diabetes via beta-cell dysfunction in east Asian people

  Daisuke Yabe; Yutaka Seino

  LANCET DIABETES & ENDOCRINOLOGY, Jan. 2016, Peer-reviewed, Invited

  
• Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance

  Sae Aoyama-Sasabe; Mitsuo Fukushima; Xin Xin; Ataru Taniguchi; Yoshikatsu Nakai; Rie Mitsui; Yoshitaka Takahashi; Hideaki Tsuji; Daisuke Yabe; Koichiro Yasuda; Takeshi Kurose; Nobuya Inagaki; Yutaka Seino

  JOURNAL OF DIABETES RESEARCH, 2016, Peer-reviewed

  Access this paper :

  
• A case of insulinoma with non-alcoholic fatty liver disease: Roles of hyperphagia and hyperinsulinemia in pathogenesis of the disease

  Mariyo Rokutan; Daisuke Yabe; Izumi Komoto; Takeshi Kurose; Jun Kawai; Takefumi Nakamura; Masayuki Imamura; Yutaka Seino

  Endocrine Journal, 28 Nov. 2015, Peer-reviewed

  
• Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining beta-cell function and achievement of HbA1c target one year after initiation

  Ryota Usui; Daisuke Yabe; Hitoshi Kuwata; Kenta Murotani; Takeshi Kurose; Yutaka Seino

  JOURNAL OF DIABETES AND ITS COMPLICATIONS, Nov. 2015, Peer-reviewed

  
• Long-term safety of once-daily lixisenatide in Japanese patients with type 2 diabetes mellitus: GetGoal-Mono-Japan

  Yutaka Seino; Daisuke Yabe; Akane Takami; Elisabeth Niemoeller; Hiroki Takagi

  JOURNAL OF DIABETES AND ITS COMPLICATIONS, Nov. 2015, Peer-reviewed

  
• Efficacy and Safety of Lixisenatide in Japanese Patients with Type 2 Diabetes Insufficiently Controlled with Basal Insulin +/- Sulfonylurea: A Subanalysis of the GetGoal-L-Asia Study

  Y. Seino; Y. Ikeda; E. Niemoeller; D. Watanabe; H. Takagi; D. Yabe; N. Inagaki

  HORMONE AND METABOLIC RESEARCH, Nov. 2015, Peer-reviewed

  
• Why are incretin-based therapies more efficient in East Asians? Perspectives from the pathophysiology of type 2 diabetes and East Asian dietary habits

  Yabe D; Kuwata H; Iwasaki M; Seino Y

  European Medical Journal, Nov. 2015, Peer-reviewed, Invited

  
• Evidence-based practice guideline for the treatment for diabetes in Japan 2013

  Naoko Tajima; Mitsuhiko Noda; Hideki Origasa; Hiroshi Noto; Daisuke Yabe; Yukihiro Fujita; Atsushi Goto; Kei Fujimoto; Masaya Sakamoto; Masakazu Haneda

  Diabetology International, 04 Sep. 2015, Peer-reviewed

  
• Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: assessment of composite end-points

  Daisuke Yabe; Hitoshi Kuwata; Ryota Usui; Takeshi Kurose; Yutaka Seino

  CURRENT MEDICAL RESEARCH AND OPINION, Jul. 2015, Peer-reviewed, Invited

  
• Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events

  Daisuke Yabe; Rie Nishikino; Makiko Kaneko; Masahiro Iwasaki; Yutaka Seino

  EXPERT OPINION ON DRUG SAFETY, Jun. 2015, Peer-reviewed

  
• beta Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians

  Daisuke Yabe; Yutaka Seino; Mitsuo Fukushima; Susumu Seino

  CURRENT DIABETES REPORTS, Jun. 2015, Peer-reviewed, Invited

  
• A case of hypoglycemia due to illegitimate sexual enhancement medication

  Naoki Kuramoto; Daisuke Yabe; Takeshi Kurose; Yutaka Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Apr. 2015, Peer-reviewed

  
• Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients

  Daisuke Yabe; Akira Kuroe; Koin Watanabe; Masahiro Iwasaki; Akihiro Hamasaki; Yoshiyuki Hamamoto; Norio Harada; Shunsuke Yamane; Soushou Lee; Kenta Murotani; Carolyn F. Deacon; Jens J. Holst; Tsutomu Hirano; Nobuya Inagaki; Takeshi Kurose; Yutaka Seino

  JOURNAL OF DIABETES AND ITS COMPLICATIONS, Apr. 2015, Peer-reviewed

  
• Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of DPP-4 inhibitors with other oral antidiabetic drugs

  D. Yabe; H. Kuwata; M. Kaneko; C. Ito; R. Nishikino; K. Murorani; T. Kurose; Y. Seino

  DIABETES OBESITY & METABOLISM, Apr. 2015, Peer-reviewed

  
• Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal-S

  Yukiko Onishi; Elisabeth Niemoeller; Yukio Ikeda; Hiroki Takagi; Daisuke Yabe; Yutaka Seino

  JOURNAL OF DIABETES INVESTIGATION, Mar. 2015, Peer-reviewed

  
• Discussion Meeting on Care and Treatment of Obesity Syndrome: Latest Approach through Nutrition, Diets, Exercise, Lifestyle Modification and Psychological Aspects

  Hiroaki Masuzaki; Daisuke Yabe; Yukiko Onishi; Yoko Matsuzawa; Yayoi Matsuda

  Nihon Naika Gakkai Zasshi, 2015

  
• 低エネルギー食とGLP-1受容体作動薬により著明な減量に成功しえた高度肥満を伴う2型糖尿病の一例

  松本実紀; 表孝徳; 廣瀬直樹; 平沢良和; 北谷直美; 矢部大介; 黒瀬健; 清野裕

  日本病態栄養学会学会誌, 2015, Peer-reviewed

  
• Defining the role of GLP-1 receptor agonists for individualized treatment of type 2 diabetes

  Daisuke Yabe; Yutaka Seino

  Expert Review of Endocrinology and Metabolism, 01 Nov. 2014, Peer-reviewed, Invited

  
• Relationship and factors responsible for regulating fasting and post-challenge plasma glucose levels in the early stage development of type 2 diabetes mellitus

  Sae Aoyama-Sasabe; Xin Xin; Ataru Taniguchi; Yoshikatsu Nakai; Rie Mitsui; Hideaki Tsuji; Daisuke Yabe; Koichiro Yasuda; Takeshi Kurose; Nobuya Inagaki; Yutaka Seino; Mitsuo Fukushima

  JOURNAL OF DIABETES INVESTIGATION, Nov. 2014, Peer-reviewed

  
• Alogliptin for the treatment of Type 2 diabetes

  Yutaka Seino; Daisuke Yabe

  Expert Review of Endocrinology and Metabolism, 01 Nov. 2014, Peer-reviewed, Invited

  
• Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus

  W. D. Strain; X. Cos; M. Hirst; S. Vencio; V. Mohan; Z. Voko; D. Yabe; M. Blueher; P. M. Paldanius

  DIABETES RESEARCH AND CLINICAL PRACTICE, Sep. 2014, Peer-reviewed

  
• Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?

  Daisuke Yabe; Yutaka Seino

  JOURNAL OF DIABETES INVESTIGATION, Sep. 2014, Peer-reviewed, Invited

  
• The role of chronobiology and circadian rhythms in type 2 diabetes mellitus: implications for management of diabetes

  Kurose T; Hyo T; Yabe D; Seino Y

  ChronoPhysiology and Therapy, Jul. 2014, Peer-reviewed, Invited

  
• Factors influencing the durability of the glucose-lowering effect of sitagliptin combined with a sulfonylurea

  Akira Kubota; Daisuke Yabe; Akira Kanamori; Akira Kuroe; Nobuo Takahashi; Tatsuhiko Saito; Ikuro Matsuba; Koichiro Nabe; Takeshi Kurose; Yutaka Seino

  JOURNAL OF DIABETES INVESTIGATION, Jul. 2014, Peer-reviewed

  
• Alogliptin benzoate for the treatment of type 2 diabetes

  Yutaka Seino; Daisuke Yabe

  EXPERT OPINION ON PHARMACOTHERAPY, Apr. 2014, Peer-reviewed, Invited

  
• Circulating TNF Receptor 2 is Closely Associated with the Kidney Function in Non-Diabetic Japanese Subjects

  Tomoyuki Kurashina; Shoichiro Nagasaka; Naoya Watanabe; Daisuke Yabe; Noriko Sugi; Kazuko Nin; Masaya Hosokawa; Yoshio Nomura; Mitsuo Fukushima; Yoshikatsu Nakai; Fusanori Nishimura; Ataru Taniguchi

  JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, Peer-reviewed

  
• 関電糖尿病フェスタ2013」におけるアンケート調査による「世界糖尿病デー」の意識調査

  廣瀬直樹; 矢部大介; 渡邊好胤; 横田香世; 小林有美子; 松元知子; 江藤博昭; 坂口健治; 岡本朋子; 平沢良和; 北谷直美; 黒瀬健; 清野裕

  日本病態栄養学会学会誌 255-259, 2014, Peer-reviewed

  
• 腎機能低下２型糖尿病患者におけるリラグルチドの有効性、安全性および食事療法との関連性の検討

  安原章浩; 臼井亮太; 岩崎真宏; 桑田仁司; 渡邊好胤; 表孝徳; 矢部大介; 北谷直美; 古宮俊幸; 黒瀬健

  日本病態栄養学会学会誌, 2014, Peer-reviewed

  
• Incretin actions beyond the pancreas: lessons from knockout mice

  Daisuke Yabe; Yutaka Seino

  CURRENT OPINION IN PHARMACOLOGY, Dec. 2013, Peer-reviewed, Invited

  
• Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced beta-cell function

  Ryota Usui; Daisuke Yabe; Hitoshi Kuwata; Shuichi Fujiwara; Koin Watanabe; Takanori Hyo; Akihiro Yasuhara; Masahiro Iwasaki; Naomi Kitatani; Kyoko Kuwabara; Kayo Yokota; Takeshi Kurose; Yutaka Seino

  JOURNAL OF DIABETES INVESTIGATION, Nov. 2013, Peer-reviewed

  
• Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic alpha cells in vivo

  Daisuke Yabe; Mariyo Rokutan; Yoshiyuki Miura; Izumi Komoto; Ryota Usui; Hitoshi Kuwata; Koin Watanabe; Takanori Hyo; Takeshi Kurose; Terumi Nagamatsu; Shinobu Shimizu; Jun Kawai; Masayuki Imamura; Yutaka Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Oct. 2013, Peer-reviewed

  
• Improvement of fasting plasma glucose level after ingesting moderate amount of dietary fiber in Japanese men with mild hyperglycemia and visceral fat obesity

  Akira Kobayakawa; Tomoo Suzuki; Takao Ikami; Morio Saito; Daisuke Yabe; Yutaka Seino

  Journal of Dietary Supplements, Jun. 2013, Peer-reviewed

  
• Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas

  Yutaka Seino; Daisuke Yabe

  Journal of Diabetes Investigation, Mar. 2013, Peer-reviewed, Invited

  
• Circulating TNF receptor 2 is associated with the development of chronic kidney disease in non-obese Japanese patients with type 2 diabetes

  Yoshio Izumi; Daisuke Yabe; Ataru Taniguchi; Mitsuo Fukushima; Yoshikatsu Nakai; Masaya Hosokawa; Takahide Okumura; Kazuko Nin; Kazunari Matsumoto; Fusanori Nishimura; Shoichiro Nagasaka; Yutaka Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Feb. 2013, Peer-reviewed

  
• 日本人の体質と疾病とくに糖尿病－食の歴史をモデルとして

  清野裕; 矢部大介; 黒瀬健

  日本体質医学会雑誌, 2013, Invited

  
• ２．経口血糖降下薬における位置づけ

  矢部大介

  糖尿病, 2013, Peer-reviewed

  
• Dipeptidyl-peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations

  Takafumi Senmaru; Michiaki Fukui; Kanae Kobayashi; Hiroya Iwase; Shinobu Inada; Hiroshi Okada; Mai Asano; Masahiro Yamazaki; Goji Hasegawa; Naoto Nakamura; Masahiro Iwasaki; Daisuke Yabe; Takeshi Kurose; Yutaka Seino

  JOURNAL OF DIABETES INVESTIGATION, Dec. 2012, Peer-reviewed

  
• Drug-induced generalized itching erythema in diabetes mellitus receiving dipeptidyl peptidase-IV inhibitors plus metformin

  Nakatani K; Kurose T; Watanabe K; Matsumoto M; Fujiwara S; Usui R; Kuwata H; Hyo T; Yabe D; Seino Y

  Diabetes Therapy, Oct. 2012, Peer-reviewed

  
• Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels

  Masahiro Iwasaki; Fuminori Hoshian; Tomoko Tsuji; Naoki Hirose; Tomoko Matsumoto; Naomi Kitatani; Kenji Sugawara; Ryota Usui; Hitoshi Kuwata; Kazu Sugizaki; Yuka Kitamoto; Shuichi Fujiwara; Koin Watanabe; Takanori Hyo; Takeshi Kurose; Yutaka Seino; Daisuke Yabe

  JOURNAL OF DIABETES INVESTIGATION, Oct. 2012, Peer-reviewed

  
• Dipeptidyl peptidase-4 inhibitors and prevention of bone fractures: Effects beyond glyemic control

  Daisuke Yabe; Yutaka Seino

  JOURNAL OF DIABETES INVESTIGATION, Aug. 2012, Peer-reviewed, Invited

  
• Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese

  Rie Mitsui; Mitsuo Fukushima; Ataru Taniguchi; Yoshikatsu Nakai; Sae Aoyama; Yoshitaka Takahashi; Hideaki Tsuji; Daisuke Yabe; Koichiro Yasuda; Takeshi Kurose; Toshiko Kawakita; Yutaka Seino; Nobuya Inagaki

  JOURNAL OF DIABETES INVESTIGATION, Aug. 2012, Peer-reviewed

  
• Glucagon-like peptide-1 secretion by direct stimulation of L cells with luminal sugar vs non-nutritive sweetener

  Kenichi Sakurai; Eun Young Lee; Asuka Morita; Sadao Kimura; Harukiyo Kawamura; Atsushi Kasamatsu; Masashi Shiiba; Daisuke Yabe; Koutaro Yokote; Takashi Miki

  JOURNAL OF DIABETES INVESTIGATION, Apr. 2012, Peer-reviewed

  
• Smoking and adipose tissue inflammation suppress leptin expression in Japanese obese males: potential mechanism of resistance to weight loss among Japanese obese smokers

  Shintaro Nagayasu; Shigeki Suzuki; Akiko Yamashita; Ataru Taniguchi; Mitsuo Fukushima; Yoshikatsu Nakai; Kazuko Nin; Naoya Watanabe; Shoichiro Nagasaka; Daisuke Yabe; Fusanori Nishimura

  TOBACCO INDUCED DISEASES, Feb. 2012, Peer-reviewed

  
• Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes

  Daisuke Yabe; Koin Watanabe; Kenji Sugawara; Hitoshi Kuwata; Yuka Kitamoto; Kazu Sugizaki; Shuichi Fujiwara; Masahiro Hishizawa; Takanori Hyo; Kyoko Kuwabara; Kayo Yokota; Masahiro Iwasaki; Naomi Kitatani; Takeshi Kurose; Nobuya Inagaki; Yutaka Seino

  JOURNAL OF DIABETES INVESTIGATION, Feb. 2012, Peer-reviewed

  
• Drug-induced generalized skin eruption in a diabetes mellitus patient receiving a dipeptidyl peptidase-4 inhibitor plus metformin

  Kaori Nakatani; Takeshi Kurose; Takanori Hyo; Koin Watanabe; Daisuke Yabe; Terue Kawamoto; Yutaka Seino

  Diabetes Therapy, 2012, Peer-reviewed

  
• A case of triple cancer of the pancreas, colon, and peripheral nerve sheath in type 2 diabetes found by progressive body weight loss and deteriorating glycemic control

  Rokutan M; Yabe D; Usui R; Sugawara K; Kitamoto Y; Kuwata H; Sugizaki K; Fujiwara S; Watanabe K; Hyo T; Kawai J; Hosoda Y; Awane M; Taki Y; Tachi H; Ueda Y; Mizuno H; Kurose T; Seino Y

  Journal of the Japan Diabetes Society, 2012, Peer-reviewed

  
• インクレチン療法の有効性を高める食事療法、運動療法の確立に向けて

  矢部大介; 岩崎真宏; 北谷直美; 黒瀬健; 清野裕

  関西電力病院医学雑誌, 2012

  
• A Case of Triple Cancer of the Pancreas, Colon, and Peripheral Nerve Sheath in Type 2 Diabetes found by Progressive Body Weight Loss and Deteriorating Glycemic Control

  ROKUTAN Mariyo; YABE Daisuke; USUI Ryota; SUGAWARA Kenji; KITAMOTO Yuka; KUWATA Hitoshi; SUGIZAKI Kazu; FUJIWARA Syuichi; WATANABE Koin; HYO Takanori; KAWAI Jun; HOSODA Yohei; AWANE Masaaki; TAKI Yoshirou; TACHI Hidekazu; UEDA Yoshiaki; MIZUNO Hiroshi; KUROSE Takeshi; SEINO Yutaka

  Journal of the Japan Diabetes Society, 2012, Peer-reviewed

  
• Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and beta cell preservation

  Daisuke Yabe; Yutaka Seino

  PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, Nov. 2011, Peer-reviewed, Invited

  
• Circadian rhythms and diabetes

  Takeshi Kurose; Daisuke Yabe; Nobuya Inagaki

  JOURNAL OF DIABETES INVESTIGATION, Jun. 2011, Peer-reviewed

  
• [Immunoassays for the incretin hormones GIP and GLP-1].

  Daisuke Yabe; Yutaka Seino

  Nihon rinsho. Japanese journal of clinical medicine, May 2011

  
• Smoking, white blood cell counts, and TNF system activity in Japanese male subjects with normal glucose tolerance

  Naoya Watanabe; Mitsuo Fukushima; Ataru Taniguchi; Takahide Okumura; Yoshio Nomura; Fusanori Nishimura; Sae Aoyama; Daisuke Yabe; Yoshio Izumi; Ryoichi Ohtsubo; Yoshikatsu Nakai; Shoichiro Nagasaka

  TOBACCO INDUCED DISEASES, 2011, Peer-reviewed

  
• Liraglutide in adults with type 2 Diabetes: Global perspective on safety, efficacy and patient preference

  Daisuke Yabe; Yutaka Seino

  Clinical Medicine Insights: Endocrinology and Diabetes, 2011, Peer-reviewed, Invited

  
• 糖尿病カンバセーション・マップ^を用いた療養指導の有用性 : 質問紙を用いた検討

  矢部 大介; 東山 弘子; 小倉 雅仁; 原島 伸一; 山田 千積; 北谷 直美; 稲垣 暢也; 清野 裕

  日本病態栄養学会誌, 25 Nov. 2010, Peer-reviewed

  
• GIP and GLP-1, the two incretin hormones: Similarities and differences

  Yutaka Seino; Mitsuo Fukushima; Daisuke Yabe

  JOURNAL OF DIABETES INVESTIGATION, Feb. 2010, Peer-reviewed, Invited

  
• Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls

  Daisuke Yabe; Akira Kuroe; Soushou Lee; Koin Watanabe; Takanori Hyo; Masahiro Hishizawa; Takeshi Kurose; Carolyn F. Deacon; Jens J. Holst; Tsutomu Hirano; Nobuya Inagaki; Yutaka Seino

  JOURNAL OF DIABETES INVESTIGATION, Feb. 2010, Peer-reviewed

  
• Intact Glucagon-like Peptide-1 Levels are not Decreased in Japanese Patients with Type 2 Diabetes

  Soushou Lee; Daisuke Yabe; Kyoko Nohtomi; Michiya Takada; Ryou Morita; Yutaka Seino; Tsutomu Hirano

  ENDOCRINE JOURNAL, Feb. 2010, Peer-reviewed

  
• The Role of Family Nutritional Support in Japanese Patients with Type 2 Diabetes Mellitus

  Koin Watanabe; Takeshi Kurose; Naomi Kitatani; Daisuke Yabe; Masahiro Hishizawa; Takanori Hyo; Yutaka Seino

  INTERNAL MEDICINE, 2010, Peer-reviewed

  
• 糖尿病カンバセーション・マップTM －会話を通して学ぶ、糖尿病療養の発見学習教材－

  矢部大介; 東山弘子

  日本病態栄養学会学会誌, 2010, Peer-reviewed

  
• Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase

  Masahito Horiguchi; Tadashi Inoue; Tetsuya Ohbayashi; Maretoshi Hirai; Kazuo Noda; Lihua Y. Marmorstein; Daisuke Yabe; Kyoko Takagi; Tomoya O. Akama; Toru Kita; Takeshi Kimura; Tomoyuki Nakamura

  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Nov. 2009, Peer-reviewed

  
• ラクトアイスの間食が糖尿病患者の血糖・C－ペプチド・中性脂肪に与える影響－糖アルコール及び食物繊維を使用する意義について－

  矢部大介; 大屋道洋; 北谷直美; 渡邊好胤; 菱澤方洋; 表孝徳; 黒江彰; 辻とも子; 松元知子; 奥野貴央; 八木章; 宮木康有; 福島光夫; 稲垣暢也; 黒瀬健; 清野裕

  日本病態栄養学会学会誌, 2009, Peer-reviewed

  
• A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion

  Daisuke Yabe; Akira Kuroe; Michihiro Ohya; Koin Watanabe; Naomi Kitatani; Masayuki Oku; Takeshi Kurose; Yutaka Seino

  Diabetes Research and Clinical Practice, Nov. 2008, Peer-reviewed

  
• Rbp-j regulates expansion of pancreatic epithelial cells and their differentiation into exocrine cells during mouse development

  Junji Fujikura; Kiminori Hosoda; Yoshiya Kawaguchi; Michio Noguchi; Hiroshi Iwakura; Shinji Odori; Eisaku Mori; Tsutomu Tomita; Masakazu Hirata; Ken Ebihara; Hiroaki Masuzaki; Akihisa Fukuda; Kenichiro Furuyama; Kenji Tanigaki; Daisuke Yabe; Kazuwa Nakao

  DEVELOPMENTAL DYNAMICS, Oct. 2007, Peer-reviewed

  
• Multiple roles of Notch signaling in cochlear development

  Shinji Takebayashi; Norio Yamamoto; Daisuke Yabe; Hitoshi Fukuda; Ken Kojima; Juichi Ito; Tasuku Honjo

  DEVELOPMENTAL BIOLOGY, Jul. 2007, Peer-reviewed

  
• Generation of a conditional knockout allele for mammalian Spen protein Mint/SHARP

  Daisuke Yabe; Hitoshi Fukuda; Misayo Aoki; Shuichi Yamada; Shinji Takebayashi; Reiko Shinkura; Norio Yamamoto; Tasuku Honjo

  GENESIS, May 2007, Peer-reviewed

  
• Msx2-interacting nuclear target protein (Mint) deficiency reveals negative regulation of early thyrnocyte differentiation by Notch/RBP-J signaling

  Masayuki Tsuji; Reiko Shinkura; Kazuki Kuroda; Daisuke Yabe; Tasuku Honjo

  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Jan. 2007, Peer-reviewed

  
• Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice

  Ai Kotani; Naoki Kakazu; Tatsuaki Tsuruyama; Il-mi Okazaki; Masamichi Muramatsu; Kazuo Kinoshita; Hitoshi Nagaoka; Daisuke Yabe; Tasuku Honjo

  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Jan. 2007, Peer-reviewed

  
• Inhibition of Notch/RBP-J signaling induces hair cell formation in neonate mouse cochleas

  N Yamamoto; K Tanigaki; M Tsuji; D Yabe; J Ito; T Honjo

  JOURNAL OF MOLECULAR MEDICINE-JMM, Jan. 2006, Peer-reviewed

  
• Notch/Rbp-j signaling prevents premature endocrine and ductal cell differentiation in the pancreas

  J Fujikura; K Hosoda; H Iwakura; T Tomita; M Noguchi; H Masuzaki; K Tanigaki; D Yabe; T Honjo; K Nakao

  CELL METABOLISM, Jan. 2006, Peer-reviewed

  
• Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol

  N Sever; BL Song; D Yabe; JL Goldstein; MS Brown; RA DeBose-Boyd

  JOURNAL OF BIOLOGICAL CHEMISTRY, Dec. 2003, Peer-reviewed

  
• Liver-specific mRNA for Insig-2 down-regulated by insulin: Implications for fatty acid synthesis

  D Yabe; R Komuro; GS Liang; JL Goldstein; MS Brown

  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Mar. 2003, Peer-reviewed

  
• Three mutations in sterol-sensing domain of SCAP block interaction with insig and render SREBP cleavage insensitive to sterols

  D Yabe; ZP Xia; CM Adams; RB Rawson

  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Dec. 2002, Peer-reviewed

  
• Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins

  D Yabe; MS Brown; JL Goldstein

  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Oct. 2002, Peer-reviewed

  
• Sterols block binding of COPII proteins to SCAP, thereby controlling SCAP sorting in ER

  PJ Espenshade; WP Li; D Yabe

  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Sep. 2002, Peer-reviewed

  
• Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER

  T Yang; PJ Espenshade; ME Wright; D Yabe; Y Gong; R Aebersold; JL Goldstein; MS Brown

  CELL, Aug. 2002, Peer-reviewed

  
• Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes

  A Nohturfft; D Yabe; JL Goldstein; MS Brown; PJ Espenshade

  CELL, Aug. 2000, Peer-reviewed

  
• DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries

  T Nakamura; P Ruiz-Lozano; Lindner, V; D Yabe; M Taniwaki; Y Furukawa; K Kobuke; K Tashiro; ZJ Lu; NL Andon; R Schaub; A Matsumori; S Sasayama; KR Chien; T Honjo

  JOURNAL OF BIOLOGICAL CHEMISTRY, Aug. 1999, Peer-reviewed

  
• 日本人正常集団におけるHIV-1耐性遺伝子多型の頻度

  池川 雅哉; 田代 啓; 矢部 大介; 本庶 佑

  生化学, Aug. 1999

  
• Molecular cloning, characterization, and chromosomal localization of FKBP23, a novel FK506-binding protein with Ca2+-binding ability

  T Nakamura; D Yabe; N Kanazawa; K Tashiro; S Sasayama; T Honjo

  GENOMICS, Nov. 1998, Peer-reviewed

  
• Human calumenin gene (CALU): cDNA isolation and chromosomal mapping to 7q32

  D Yabe; M Taniwaki; T Nakamura; N Kanazawa; K Tashiro; T Honjo

  GENOMICS, Apr. 1998, Peer-reviewed

  
• Human calumenin gene (CALU): cDNA isolation and chromosomal mapping to 7q32

  Yabe, D.; Taniwaki, M.; Nakamura, T.; Kanazawa, N.; Tashiro, K.; Honjo, T.

  Genomics, Apr. 1998, Peer-reviewed

  
• Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant

  Cheryl Winkler; William Modi; Michael W. Smith; George W. Nelson; Xueyun Wu; Mary Carrington; Michael Dean; Tasaku Honjo; Kai Tashiro; D. Yabe; Susan Buchbinder; Eric Vittinghoff; James J. Goedert; Thomas R. O'Brien; Lisa P. Jacobson; Roger Detels; Sharyne Donfield; Anne Willoughby; Edward Gomperts; David Vlahov; John Phair; Stephen J. O'Brien

  Science, 16 Jan. 1998, Peer-reviewed

  
• Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant

  C Winkler; W Modi; MW Smith; GW Nelson; XY Wu; M Carrington; M Dean; T Honjo; K Tashiro; D Yabe; S Buchbinder; E Vittinghoff; JJ Goedert; TR O'Brien; LP Jacobson; R Detels; S Donfield; A Willoughby; E Gomperts; D Vlahov; J Phair; SJ O'Brien

  SCIENCE, Jan. 1998, Peer-reviewed

  
• Calumenin, a Ca2+-binding protein retained in the endoplasmic reticulum with a novel carboxyl-terminal sequence, HDEF

  D Yabe; T Nakamura; N Kanazawa; K Tashiro; T Honjo

  JOURNAL OF BIOLOGICAL CHEMISTRY, Jul. 1997, Peer-reviewed

  

Misc.

• GLP—1 受容体作動薬の基礎から臨床応用まで

  瀬野洋平; 池口絵里; 矢部大介

  LOCO CURE, Mar. 2025, Invited, Last author, Corresponding author

  
• インクレチンの概念提唱からインクレチン受容体作動薬の登場まで

  瀬野洋平; 池口絵里; 矢部大介

  薬局, Apr. 2025, Invited, Last author, Corresponding author

  
• 糖尿病

  矢部大介

  総合診療, Feb. 2025, Invited, Lead author

  
• 膵β細胞補充療法

  本橋和也; 藤倉純二; 矢部大介

  総合診療, Feb. 2025, Peer-reviewed, Last author

  
• 地域一丸の糖尿病対策の意義と課題 後編

  矢部大介

  房総の国保, Nov. 2024, Invited

  
• はじめに（GLP-1受容体作動薬・GIP/GLP-1受容体作動薬 ─非臨床・臨床のエビデンスと実臨床における注意点）

  矢部大介

  医学のあゆみ, Dec. 2023, Invited

  
• SGLT2阻害薬の最新エビデンス

  南野寛人; 藤田義人; 矢部大介

  糖尿病・内分泌プラクティス, 03 Dec. 2024, Invited, Last author

  
• GIP/GLP-1 dual agonistの特性と効果，安全性

  安田拓真; 原田範雄; 矢部大介

  実験医学, 01 Sep. 2024, Invited, Last author, Corresponding author

  
• 地域一丸の糖尿病対策の意義と課題 前編

  矢部大介

  房総の国保, Sep. 2024, Invited, Lead author, Last author, Corresponding author

  
• スティグマとアドボカシー

  矢部大介

  糖尿病ケア, Aug. 2024, Invited, Lead author, Last author, Corresponding author

  
• A Consensus Statement from the Japan Diabetes Society: A Proposed Algorithm for Pharmacotherapy in People With Type 2 Diabetes (the Second Edition)

  坊内良太郎; 坊内良太郎; 近藤龍也; 近藤龍也; 太田康晴; 太田康晴; 後藤温; 田中大祐; 佐藤博亮; 矢部大介; 西村理明; 原田範雄; 原田範雄; 神谷英紀; 神谷英紀; 鈴木亮; 鈴木亮; 山内敏正; 山内敏正

  糖尿病(Web), 2023

  
• Case 23-2018: A man with episodes of confusion and hypoglycemia

  Takaaki Murakami; Daisuke Yabe; Nobuya Inagaki

  New England Journal of Medicine, 08 Nov. 2018

  
• 血糖値だけではない糖尿病のある人の食事

  高橋佳大; 水野正巳; 矢部大介

  臨床雑誌内科, 01 May 2024, Last author, Corresponding author

  
• 患者さんからよく尋ねられる内科診療のQuestion Q大福などの甘いものを食べると家族に怒られます。糖尿病があったら、絶対に食べてはだめなんですか？

  水野正巳; 矢部大介

  臨床雑誌内科, 01 Apr. 2024, Invited, Last author, Corresponding author

  
• インクレチン関連薬（DPP-4阻害薬、GLP-1受容体作動薬）

  堀谷愛美; 加藤丈博; 矢部大介

  Current Therapy, 01 Feb. 2024, Invited, Last author, Corresponding author

  
• もう一つのインクレチンGIP

  矢部大介

  糖尿病ライフさかえ, 15 Nov. 2023, Invited, Lead author, Last author, Corresponding author

  
• One Medicine創薬シーズ開発・育成研究教育拠点（COMIT）

  矢部大介

  東海国立大学機構統合報告書「INTEGRATED REPORT2023」, Nov. 2023

  
• 質疑応答 プロからプロへ 持続性GIP/GLP-1受容体作動薬の使い分けと位置づけについて

  矢部大介

  日本医事新報, Aug. 2023, Invited, Lead author, Corresponding author

  
• GLP-1受容体作動薬とNASH/NAFLD

  矢部大介

  Medical View Point, Jul. 2023, Peer-reviewed, Invited, Lead author, Last author, Corresponding author

  
• 東海国立大学機構One Medicine創薬シーズ開発・育成研究教育拠点

  矢部大介

  G-NICE News Letter, Jun. 2023, Invited

  
• DPP-4阻害薬とGLP-1受容体作動薬

  酒井 麻有; 加藤 丈博; 矢部 大介

  綜合診療, Mar. 2023, Invited, Last author, Corresponding author

  
• GLP-1受容体作動薬の注射剤と経口剤の相違点と使い分け

  小出祐也; 窪田創大; 加藤丈博; 矢部大介

  月刊薬事, Jan. 2023, Invited, Last author, Corresponding author

  
• 経腸栄養時における血糖管理は？

  水野正巳; 西村佳代子; 矢部大介

  シリーズGノート 患者さんに合わせた糖尿病治療ができる 血糖管理と薬剤選択の大原則, Oct. 2022, Invited, Last author, Corresponding author

  
• 食事に役立つ「食テク」の極意

  矢部大介

  NHKあさイチ, Sep. 2022, Invited, Lead author

  
• Personal health record (PHR)を活用した2型糖尿病治療のこれから

  福井道明; 矢部大介

  DITN, Sep. 2022, Invited

  
• GLP-1受容体作動薬の臨床的有用性

  窪田紗希; 丸山貴子; 山田浩司; 矢部大介

  月刊糖尿病, Aug. 2022, Invited, Last author, Corresponding author

  
• SGLT2阻害薬の臨床的有用性

  髙橋佳大; 藤澤太郎; 矢部大介

  月刊糖尿病, Aug. 2022, Invited, Last author, Corresponding author

  
• スティグマ・アドボカシー、専門医との連携

  加藤 丈博; 酒井 麻有; 矢部 大介

  内科, May 2022, Invited

  
• New Topics of GLP-1 receptor agonists

  Sho Higuchi; Sodai Kubota; Daisuke Yabe

  Nippon Rinsho, Apr. 2022, Invited, Last author, Corresponding author

  
• 経口GLP-1受容体作動薬～胃粘膜から吸収されるGLP-1受容体作動薬

  窪田創大; 加藤丈博; 水野正巳; 矢部大介

  月間糖尿病, Mar. 2022, Invited, Last author, Corresponding author

  
• 糖尿病、正しく知って発症・重症化を予防しよう！－糖尿病地域連携パスを活用してあなた仕様の糖尿病治療を実現

  矢部大介

  経済月報, Feb. 2022, Invited, Lead author, Last author, Corresponding author

  
• GLP-1受容体作動薬

  平田はるか; 窪田創大; 矢部大介

  Medicina, Jan. 2022, Invited, Last author, Corresponding author

  
• インスリン

  平田はるか; 窪田創大; 矢部大介

  Medicina, Jan. 2022, Invited, Last author, Corresponding author

  
• 糖尿病の薬、どう選ぶ？

  津村和大; 野見山崇; 矢部大介

  Medicina, Jan. 2022, Invited

  
• 先生 こんちには

  矢部大介

  KNG, 20 Dec. 2021, Invited, Lead author, Last author, Corresponding author

  
• 高齢者糖尿病における食事療法・運動療法の実際

  髙橋佳大; 水野正巳; 山川顕吾; 林慎; 村上正憲; 矢部大介

  月間糖尿病, Nov. 2021, Invited, Last author, Corresponding author

  
• 経口GLP-1受容体作動薬の登場 ─新しいdrug deliveryと薬剤効果

  窪田紗希; 丸山貴子; 山田浩司; 矢部大介

  糖尿病プラクティス, Nov. 2021, Invited

  
• 高齢糖尿病患者におけるSGLT2阻害薬の期待と注意点－心血管・腎イベントに対する効果－

  堀谷愛美; 髙橋佳大; 窪田創大; 加藤丈博; 矢部大介

  Progress in medicine, Sep. 2021, Invited, Last author, Corresponding author

  
• GLP-1/GIP共受容体作動薬

  小出祐也; 窪田創大; 加藤丈博; 林慎; 村山正憲; 矢部大介

  糖尿病・内分泌代謝科, Sep. 2021, Peer-reviewed, Invited, Last author

  
• 自宅で出来る血糖コントロールの工夫 ～食べる順番の意識とSMBGの理解度が合併症予防につながる

  矢部大介

  AID, Sep. 2021, Invited

  
• 高齢糖尿病患者にはしっかり食べさせたほうがよいこともある

  山川顕吾; 矢部大介

  内科, Sep. 2021, Invited, Last author, Corresponding author

  
• 第４次対糖尿病戦略５か年計画の概略～1000万通りの個別化医療提供に向けた多面的対策の必要性～

  矢部大介

  Calm, Jul. 2021, Invited, Lead author, Last author, Corresponding author

  
• 対糖尿病戦略５か年計画 国民への啓発と情報発信

  矢部大介

  Medical View Point, Jul. 2021, Invited

  
• 新しい糖尿病治療薬をどのような患者さんにどう用いるか

  片山茂裕; 門脇孝; 矢部大介

  Current Therapy, May 2021, Invited

  
• 栄養素とインクレチン、糖・脂質代謝

  今泉俊則; 飯塚勝美; 大洞尚司; 矢部大介

  Lipids, Apr. 2021, Invited

  
• 「経口血糖降下薬の現状と課題 インクレチン関連薬とSGLT2阻害薬の薬学的管理のポイント

  矢部大介; 堀美智子

  調剤と情報, Apr. 2021, Invited

  
• 膠原病、内分泌疾患の迅速かつ正確な診断と最適治療を実践

  水野正巳; 矢部大介

  岐阜大学医学部附属病院 連携ニュースNEWS, Feb. 2021

  
• DPP-4阻害薬,GLP-1受容体作動薬の適正使用のポイントと使い分け

  窪田創大; 加藤丈博; 矢部大介

  医学のあゆみ, Feb. 2021, Invited, Last author, Corresponding author

  
• 膵神経内分泌腫瘍術後にIGF-1低下を認めた先端巨大症の一例

  酒井麻有; 酒井麻有; 加藤丈博; 加藤丈博; 諏訪哲也; 諏訪哲也; 堀谷愛美; 堀谷愛美; 窪田創大; 窪田創大; 廣瀬徳之; 廣瀬徳之; 鷹尾賢; 鷹尾賢; 水野正巳; 水野正巳; 廣田卓男; 廣田卓男; 飯塚勝美; 飯塚勝美; 酒々井夏子; 堀川幸男; 堀川幸男; 山本眞由美; 宮崎龍彦; 矢部大介; 矢部大介

  日本内分泌学会雑誌, 2021

  
• 糖尿病治療薬の効果と食事療法

  矢部大介

  岐阜県内科医会雑誌, Dec. 2020, Peer-reviewed, Invited, Lead author, Last author, Corresponding author

  
• 関節リウマチ患者が新型コロナウイルス、インフルエンザウイルスに対して気をつけること

  水野正巳; 伊藤公大; 矢部大介

  KNG, Dec. 2020, Invited, Last author

  
• 医師ｘ薬剤師クロストーク 地域に伝えたいこれからの糖尿病治療 －病院薬剤師篇－

  厚田幸一郎; 矢部大介

  THINK CUBE, Dec. 2020, Invited

  
• 海津市医師会病院30周年によせて

  矢部大介

  海津市医師会創立70周年記念誌・海津市医師会病院開設30周記念誌, Nov. 2020, Peer-reviewed, Invited, Lead author

  
• The Leaders

  矢部大介

  Astellas Square, Nov. 2020, Invited

  
• 専門医へ依頼すべき病態の把握と紹介のポイント

  水野正巳; 矢部大介

  Medical Practice, Oct. 2020, Invited

  
• 医師ｘ薬剤師クロストーク 地域に伝えたいこれからの糖尿病治療 －病院薬剤師篇－

  厚田幸一郎; 矢部大介

  THINK CUBE, Oct. 2020, Invited

  
• 糖尿病や肥満症に代表される生活習慣病の予防と治療における「食べる順番」の意義

  矢部大介

  栄養教諭, Sep. 2020, Invited, Lead author, Last author, Corresponding author

  
• 国民への啓発と情報発信

  矢部大介; 金子至寿佳

  一般社団法人日本糖尿病学会 第4次「対糖尿病戦略5ヵ年計画」, Aug. 2020, Lead author

  
• 糖尿病性腎症重症化予防プログラムと糖尿病連携手帳の活用

  矢部大介; 加藤丈博; 堀川幸男

  DM Ensemble, Aug. 2020, Peer-reviewed, Invited, Lead author, Corresponding author

  
• インクレチンの臨床科学とその展開

  矢部大介

  京都糖尿病医会会報, 01 Jul. 2020, Invited, Lead author, Corresponding author

  
• インクレチン関連薬による肥満症治療―Dual agonist、Triple agonistを含めて―

  小森聡子; 窪田創大; 加藤丈博; 矢部大介

  Current Therapy, Jul. 2020, Invited, Last author, Corresponding author

  
• わが国の糖尿病診療におけるインクレチン薬の歴史：上市10年を振り返る

  櫻井瑛章; 飯塚勝美; 矢部大介

  DITN, Jul. 2020, Invited, Last author, Corresponding author

  
• 地域一丸で取り組む糖尿病重症化予防

  矢部大介

  岐阜県医学会医学雑誌, Jul. 2020, Invited, Lead author, Last author, Corresponding author

  
• 糖尿病治療薬と食事療法

  窪田紗希; 桑田仁司; 窪田創大; 矢部大介

  臨牀と研究, Jul. 2020, Invited, Last author, Corresponding author

  
• 効果的で続けやすい食事療法など チームでテーラーメイド医療素推進

  矢部大介

  頼れるドクター 名古屋・尾張・岐阜 2020-2021版, Jun. 2020

  
• 糖尿病に関する教育と支援

  酒井麻有; 窪田創大; 加藤丈博; 堀川幸男; 矢部大介

  日本臨牀, Jun. 2020, Invited

  
• 糖尿病教育・支援のポイント 巻頭言

  矢部大介

  Medical View Point, May 2020, Invited

  
• 腸のスイッチ「インクレチン」に注目 ご飯の前の魚や肉で血糖値改善！

  矢部大介

  NHKガッテン！, May 2020, Invited, Lead author

  
• 「食べ順」で健康効果をきちんと得るために

  矢部大介

  Calnet, Mar. 2020, Invited, Lead author

  
• アジアの糖尿病の現状と対策

  矢部大介; 清野裕

  さかえ, Mar. 2020, Peer-reviewed, Invited, Lead author, Corresponding author

  
• 糖尿病におけるクリニカルパスの活用

  矢部大介

  糖尿病最新の治療2019-2021, Feb. 2020, Invited, Lead author, Last author, Corresponding author

  
• SGLT2阻害薬の心・腎保護効果

  劉彦言; 飯塚勝美; 矢部大介

  薬事日報, Feb. 2020, Invited, Last author, Corresponding author

  
• 日本の糖尿病研究と治療：これまでとこれからの10年

  清野裕; 稲垣暢也; 植木浩二郎; 綿田裕孝; 山田祐一郎; 矢部大介

  Journal of Diabetes Strategy, Feb. 2020

  
• サンスター「糖尿病患者の口腔管理」

  西村英紀; 矢部大介

  サンスター「糖尿病患者の口腔管理」, Jan. 2020, Invited

  
• 食物繊維の摂取量と糖尿病管理

  鷹尾賢; 飯塚勝美; 矢部大介

  月間糖尿病, Oct. 2019, Invited

  
• 教育記念講演 糖尿病食事療法の温故知新

  矢部 大介

  岐阜大学医学部記念会館だより, Sep. 2019, Invited, Lead author

  
• 論文投稿のススメと論文執筆の際の注意点

  岡田洋右; 矢部 大介

  Calm, Jul. 2019, Invited

  
• 食べる順番に配慮した食事療法の機序と体重管理に期待される効果

  窪田創大; 桑田仁司; 矢部大介; 矢田俊彦; 浜本芳之; 清野裕

  肥満研究, Jul. 2019, Peer-reviewed, Invited

  
• Single Cell RNA-Sequencing Dissects Proliferation of Pancreatic Beta Cells

  Hisato Tatsuoka; Daisuke Yabe; Satoko Sakamoto; Akira Watanabe; Ryota Usui; Shinsuke Tokumoto; Ainur Botagarova; Daisuke Ootani; Hisanori Goto; Muhammad Fauzi; Masahito Ogura; Nobuya Inagaki

  DIABETES, Jun. 2019

  
• Generation of a Novel Mouse Model to Study beta-Cell Proliferation

  Shinsuke Tokumoto; Daisuke Yabe; Hisato Tatsuoka; Ryota Usui; Muhammad Fauzi; Hisanori Goto; Masahito Ogura; Nobuya Inagaki

  DIABETES, Jun. 2019

  
• 食事療法のQOL

  矢部大介

  Medical View Point, Jun. 2019, Invited

  
• 口腔ケア 歯周病は血糖コントロールに影響する？

  小倉雅仁; 矢部大介

  Medicina, Jun. 2019, Invited

  
• 糖尿病診療・研究におけるIoT活用の最前線

  矢部 大介; 黒田 知宏; 松久 宗英; 脇 嘉代; 池田 香織; 岡畑 純江; 白神 敦久; 橋本 健一

  Diabetes Strategy, May 2019

  
• HLSとChREBPの相互作用による脂肪細胞のインスリン感受性制御

  飯塚勝美; 矢部 大介

  Journal of Diabetes Strategy, May 2019, Invited, Last author

  
• 糖尿病診療・研究におけるIoTの活用

  矢部 大介; 黒田知宏; 松久宗英; 脇嘉代

  Journal of Diabetes Strategy, May 2019, Invited

  
• SUSTAIN6 セマグルチド

  加藤丈博; 飯塚勝美; 矢部大介

  Current Therapy, May 2019, Invited

  
• 2型糖尿病患者における低糖質パンを用いた血糖変動とホルモン分泌の検討

  安藤 瑞穂; 清野 祐介; 森川 理佐; 根木 可奈; 轟木 秀親; 川上 司; 淺田 陽平; 良元 亮; 田中 知香; 岡本 慧子; 増田 富; 戸松 瑛介; 平塚 いづみ; 吉野 寧維; 牧 和歌子; 垣田 彩子; 四馬田 恵; 高柳 武志; 牧野 真樹; 浅井 志歩; 伊藤 明美; 藤原 結花; 桑田 仁司; 矢部 大介; 清野 裕; 鈴木 敦詞

  糖尿病, Apr. 2019

  
• インスリノーマ局在診断に対する低用量選択的動脈内カルシウム注入試験の施行経験について

  波床 朋信; 村上 隆亮; 曽根 正勝; 矢部 大介; 原田 範雄; 小倉 雅仁; 八十田 明宏; 稲垣 暢也

  日本内分泌学会雑誌, Apr. 2019

  
• 細胞周期可視化蛍光プローブFucci2aRを用いた膵β細胞増殖の新規定量法の開発

  徳本 信介; 矢部 大介; 龍岡 久登; 臼井 亮太; 後藤 久典; ファウジ・ムハンマド; ボタガロバ・アイヌラ; 小倉 雅仁; 稲垣 暢也

  糖尿病, Apr. 2019

  
• 膵β細胞におけるGPR40シグナルに注目したストア依存性カルシウム流入の意義の解明

  臼井 亮太; 矢部 大介; Fauzi Muhammad; Botagarova Ainur; 後藤 久典; 徳本 信介; 龍岡 久登; 田原 裕美子; 小林 静香; 真鍋 俊也; 黒崎 知博; Herrera Pedro Luis; 小倉 雅仁; 長嶋 一昭; 稲垣 暢也

  糖尿病, Apr. 2019

  
• RNAシークエンスとATACシークエンスを用いた,加齢における膵β細胞増殖能低下のメカニズムの解析

  龍岡 久登; 矢部 大介; 坂本 智子; 渡辺 亮; 徳本 信介; ボタガロワ・アイヌラ; 臼井 亮太; 後藤 久典; ファウジ・ムハンマド; 小倉 雅仁; 稲垣 暢也

  糖尿病, Apr. 2019

  
• 糖尿病腎症重症化予防のための戦略 全国自治体における糖尿病性腎症重症化予防プログラムの実証支援と事業評価

  古川 麻里子; 栄口 由香里; 村本 あき子; 岩竹 麻希; 野村 恵里; 安西 慶三; 植木 浩二郎; 岡村 智教; 樺山 舞; 後藤 資実; 有馬 寛; 佐野 喜子; 平田 匠; 福田 敬; 三浦 克之; 森山 美知子; 安田 宜成; 矢部 大介; 和田 隆志; 津下 一代

  糖尿病, Apr. 2019

  
• Sphingosine kinase 1-interacting proteinはインスリン及びインクレチン分泌の双方の制御因子である

  劉 彦言; 原島 伸一; 王 宇; 鈴木 和代; 徳本 信介; 臼井 亮太; 龍岡 久登; 田中 大祐; 矢部 大介; 原田 範雄; 林 良敬; 稲垣 暢也

  日本臨床分子医学会学術総会プログラム・抄録集, Apr. 2019

  
• 2型糖尿病患者における低糖質パンを用いた血糖変動とホルモン分泌の検討

  安藤 瑞穂; 清野 祐介; 森川 理佐; 根木 可奈; 轟木 秀親; 川上 司; 淺田 陽平; 良元 亮; 田中 知香; 岡本 慧子; 増田 富; 戸松 瑛介; 平塚 いづみ; 吉野 寧維; 牧 和歌子; 垣田 彩子; 四馬田 恵; 高柳 武志; 牧野 真樹; 浅井 志歩; 伊藤 明美; 藤原 結花; 桑田 仁司; 矢部 大介; 清野 裕; 鈴木 敦詞

  糖尿病, Apr. 2019

  
• DPP-4阻害薬

  野々村健太; 矢部大介

  Current Therapy, Apr. 2019, Invited

  
• GLP-1受容体作動薬の心血管・腎イベントリスクに対する効果

  後藤久典; 臼井亮太; 矢部大介

  糖尿病の最新治療, Feb. 2019

  
• 差分解説 代謝内分泌・糖尿病 透析阻止に向けた糖尿病性腎症重症化予防プログラムの全国均てん化

  矢部大介; 稲垣暢也

  日本医事新報, Feb. 2019, Peer-reviewed, Invited

  
• 膵β細胞におけるGPR40シグナルに注目したストア依存性カルシウム流入の意義の解明

  臼井亮太; 矢部大介; FAUZI Muhammad; BOTAGAROVA Ainur; 後藤久典; 徳本信介; 龍岡久登; 田原裕美子; 小林静香; 真鍋俊也; 黒崎知博; HERRERA Pedro Luis; 小倉雅仁; 長嶋一昭; 稲垣暢也

  糖尿病(Web), 2019

  
• Correction to: Japanese Clinical Practice Guideline for Diabetes 2016.

  Haneda M; Noda M; Origasa H; Noto H; Yabe D; Fujita Y; Goto A; Kondo T; Araki E

  Diabetology international, Jan. 2019, Peer-reviewed

  
• 新任教授紹介

  矢部 大介

  岐阜大学医学部記念会館だより, Jan. 2019, Invited, Lead author

  
• VOICE－岐大医学部から－ 内分泌代謝病態学分野からのメッセージ

  矢部大介

  岐阜大学大学院医学系研究科/医学部ホームページ, Jan. 2019, Peer-reviewed

  
• 糖尿病の食事療法：基本概念と最近の知見

  矢部大介

  Monthly Book Oculista, Nov. 2018, Invited

  
• 糖尿病の治療・栄養療法をめぐる最近の話題

  矢部大介

  BEQ NEWS, Oct. 2018, Invited

  
• DPP-4阻害薬の使用と炎症性腸疾患発症リスク 頻度がきわめて低く、他の大規模コホートによる追試必要

  矢部大介

  MMJ, Aug. 2018, Invited

  
• たんぱく質はどのように消費されて、体のどこではたらくの？

  矢部大介

  糖尿病ケア, Aug. 2018, Invited

  
• 脂質はどのように消費されて、体のどこではたらくの？

  矢部大介

  糖尿病ケア, Aug. 2018, Invited

  
• Effects of Dietary Instructions Including Meal-Sequence for Prediabetes Subjects-Comparison with Conventional Approach

  Daisuke Yabe; Hitoshi Kuwata; Yuuka Fujiwara; Kenta Murotani; Sanae Ito; Hiroshi Asano; Hideyuki Mishima; Hideto Takase; Noriyasu Oota; Yusuke Seino; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino

  DIABETES, Jul. 2018

  
• 疾患の理解の底上げに有効なツールや活動

  矢部大介

  月刊糖尿病, Jul. 2018, Invited

  
• Lecture Note 高齢者糖尿病治療とサルコペニア

  矢部大介

  DxM, May 2018, Peer-reviewed, Invited

  
• 糖尿病食事療法へのヒント

  矢部大介

  まるごとわかる糖尿病 知って防ごう、糖尿病読本, May 2018, Peer-reviewed, Invited

  
• 糖尿病カンバセーション・マップTM

  矢部大介

  Journal of Diabetes Strategy, May 2018, Invited

  
• GLP-1受容体作動薬 早期開始のベネフィット

  矢部大介

  月間糖尿病, May 2018, Invited

  
• 希少糖アルロースによるGLP-1放出を介した耐糖能向上 インスリン感受性と初期分泌の亢進

  岩崎 有作; 仙度 光麻; 出崎 克也; 比良 徹; 佐藤 雄大; 原 博; 山田 祐一郎; 徳田 雅明; 矢部 大介; 矢田 俊彦

  糖尿病, Apr. 2018

  
• GPR40シグナルによるグルコース応答性インスリン分泌増強機構 膵β細胞における小胞体カルシウムセンサー分子STIM1の機能解明

  臼井 亮太; 矢部 大介; 後藤 久典; Muhammad Fauzi; 徳本 信介; 龍岡 久登; 田原 裕美子; 小倉 雅仁; 稲垣 暢也

  糖尿病, Apr. 2018

  
• 全国自治体で実施可能な糖尿病性腎症重症化予防プログラムの開発と実証(第2報)

  栄口 由香里; 野村 恵里; 村本 あき子; 植木 浩二郎; 岡村 智教; 樺山 舞; 後藤 資実; 佐野 喜子; 平田 匠; 福田 敬; 三浦 克之; 森山 美知子; 安田 宜成; 矢部 大介; 和田 隆志; 津下 一代

  糖尿病, Apr. 2018

  
• DPP-4阻害薬の長期有効性と食習慣 日本人2型糖尿病患者におけるメトホルミンとの後ろ向き比較解析

  矢部 大介; 桑田 仁司; 岡本 紗希; 室谷 健太; 清野 祐介; 臼井 亮太; 龍岡 久登; 浜本 芳之; 黒瀬 健; 清野 裕

  日本内分泌学会雑誌, Apr. 2018

  
• 糖尿病治療薬の長期有効性と食習慣の関係 日本人2型糖尿病患者におけるDPP-4阻害薬とメトホルミンの後ろ向き比較解析

  岡本 紗希; 桑田 仁司; 矢部 大介; 室谷 健太; 清野 祐介; 浜本 芳之; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2018

  
• Clinical Note DPP-4阻害薬と水疱性類天疱瘡

  矢部大介; 稲垣暢也

  Diabetes Journal, Apr. 2018, Invited

  
• 糖尿病治療薬の長期有効性と食習慣の関係:日本人2型糖尿病患者におけるDPP-4阻害薬とメトホルミンの後ろ向き比較解析

  岡本紗希; 岡本紗希; 桑田仁司; 桑田仁司; 矢部大介; 矢部大介; 室谷健太; 清野祐介; 浜本芳之; 浜本芳之; 黒瀬健; 黒瀬健; 清野裕; 清野裕

  糖尿病(Web), 2018

  
• 糖尿病透析予防指導の実態に関する全国調査

  真壁 昇; 山田 祐一郎; 矢部 大介; 傍島 裕司; 柴田 大河; 清野 祐介; 幣 憲一郎; 市川 和子; 北谷 直美; 米本 孝二; 清野 裕

  日本病態栄養学会誌, Jan. 2018

  
• 糖尿病腎症の重症化予防における栄養指導に関するシステマティックレビュー

  清野 祐介; 矢部 大介; 柴田 大河; 真壁 昇; 傍島 裕司; 幣 憲一郎; 市川 和子; 北谷 直美; 米本 孝二; 山田 祐一郎; 清野 裕

  日本病態栄養学会誌, Jan. 2018

  
• インスリン、インスリン分泌指数

  矢部大介

  糖尿病ケア, Jan. 2018, Invited

  
• 75g経口ブドウ糖負荷試験

  矢部大介

  糖尿病ケア, Jan. 2018, Invited

  
• SGLT2阻害薬に関連したeDKAと炭水化物摂取

  原口卓也; 矢部大介; 清野裕

  DIABETES UPDATE, Dec. 2017, Invited

  
• 糖尿病性腎症の重症化予防にむけた食事療法とその指導法

  矢部大介; 清野裕

  医学のあゆみ, Nov. 2017, Invited

  
• GLP-1

  矢部大介

  Current Therapy, Nov. 2017, Invited

  
• 糖尿病神経障害の診断と治療の進め方 「糖尿病性多発神経障害の簡易診断基準案」に基づき診断。治療は血糖コントロールが主体

  神谷 英紀; 矢部 大介

  日本医事新報, Sep. 2017

  
• 注射製剤 (各種インスリン・GLP-1受容体作動薬) を有効・安全に使い分けるために知っておきたい絶対・相対適応と臨床指標の使いかた・読みかた

  窪田創大; 矢部大介; 清野裕

  Medical Practice, Sep. 2017, Invited

  
• SGLT2阻害薬の内服時における適正な食事療法

  矢部大介

  日本医事新報, Jul. 2017, Invited

  
• DPP-4阻害薬

  矢部大介

  医薬ジャーナル, Jul. 2017, Invited

  
• Safety and Efficacy of Luseogliflozin Added to Liraglutide in Japanese Patients with Type 2 Diabetes: Result of a 52-Week, Open-Label Study

  Yutaka Seino; Daisuke Yabe; Takashi Sasaki; Atsushi Fukatsu; Hisae Imazeki; Hidekazu Ochiai; Soichi Sakai

  DIABETES, Jun. 2017

  
• 糖尿病食事療法へのヒント

  矢部大介

  さかえ, Jun. 2017, Invited

  
• Lecture Note 内分泌疾患による糖尿病

  矢部大介

  DxM, May 2017, Invited

  
• 激増する我が国の２型糖尿病の特徴と対策

  矢部大介

  PRACTICE, May 2017, Invited

  
• ERRγによるグルコース応答性β細胞への成熟化

  矢部大介

  Diabetes Strategy, May 2017, Invited

  
• 全国自治体で実施可能な糖尿病性腎症重症化予防プログラムの開発と実証(第1報)

  村本 あき子; 栄口 由香里; 中村 誉; 野村 恵里; 松下 まどか; 植木 浩二郎; 岡村 智教; 樺山 舞; 後藤 資実; 佐野 喜子; 福田 敬; 三浦 克之; 森山 美知子; 安田 宜成; 矢部 大介; 和田 隆志; 津下 一代

  糖尿病, Apr. 2017

  
• 宿泊型新保健指導プログラム(第2報) 1年後の効果検証

  松下 まどか; 矢部 大介; 小熊 祐子; 佐野 喜子; 樺山 舞; 八谷 寛; 荒川 雅志; 村本 あき子; 津下 一代

  糖尿病, Apr. 2017

  
• インクレチン関連薬 -DPP-4阻害薬・GLP-1受容体作動薬-

  矢部大介

  医学のあゆみ, Apr. 2017, Invited

  
• 糖尿病診療における食事療法：エビデンスと実際のすすめ方

  矢部大介

  月刊 糖尿病, Feb. 2017, Invited

  
• Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes : a randomised, controlled crossover, exploratory trial

  桑田仁司; 矢部大介; 清野裕

  Diabetes strategy : journal of diabetes strategy, Feb. 2017

  
• Sodium glucose co-transporter 2 inhibitor luseogliflozin in the management of type 2 diabetes: a drug safety evaluation (vol 18, pg 1, 2017)

  D. Yabe; Y. Hamamoto; Y. Seino

  EXPERT OPINION ON DRUG SAFETY, 2017

  
• 食後血糖をどう治療する？１）食事療法

  矢部大介

  Progress in Medicine, 2017, Invited

  
• インスリン以外の糖尿病薬物療法

  矢部大介

  内科, Jan. 2017, Invited

  
• 糖尿病の分類と診断

  矢部大介

  PRACTICE, 2017, Invited

  
• 第11回国際糖尿病連合西太平洋地区会議／第8回アジア糖尿病学会年次学術集会に参加して

  矢部大介

  DITN, 2017, Invited

  
• 糖尿病診断の実際のすすめ方と注意点

  矢部大介

  PRACTICE, 2017, Invited

  
• Human islets contain four distinct subtypes of β cells

  矢部大介

  DIABETES UPDATE, 2017, Invited

  
• 消化管からのインクレチン分泌と糖尿病治療薬

  矢部大介

  Diabetes Frontier, 2017, Invited

  
• 宿泊型新保健指導(Smart Life Stay)における体験型プログラムが食習慣に与える効果について

  佐野 喜子; 中村 誉; 安田 実加; 栄口 由香里; 野村 恵里; 松下 まどか; 村本 あき子; 矢部 大介; 小熊 祐子; 八谷 寛; 荒川 雅志; 樺山 舞; 津下 一代

  日本病態栄養学会誌, Dec. 2016

  
• Effects of SGLT2 inhibitor luseogliflozin under different dietary formula in type 2 diabetes: A randomized, controlled exploratory trial

  Hitoshi Kuwata; Masahiro Iwasaki; Shigeto Kanada; Daisuke Yabe; Yutaka Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Oct. 2016

  
• Efficacy and safety comparison of sitagliptin and glimepiride in elderly Japanese patients with type 2 diabetes: START-J

  Nobuyuki Shihara; Yasuo Terauchi; Hitoshi Ishida; Masafumi Kitaoka; Jo Satoh; Daisuke Yabe; Yuichiro Yamada; Yutaka Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Oct. 2016

  
• Use of the Japanese health insurance claims database to assess safety of SGLT2 inhibitors in the management of diabetes

  Daisuke Yabe; Rie Nishikino; Nauta Yamanaka; Chie Ito; Yutaka Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Oct. 2016

  
• Long-term glucose lowering effects of sitagliptin monotherapy and dietary contents in Japanese individuals with type 2 diabetes

  Saki Okamoto; Hitoshi Kuwata; Daisuke Yabe; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Oct. 2016

  
• Clinical implication of diabetes education program declaring a goal in life for patients with diabetes mellitus

  Nagaaki Tanaka; Hiroko Higashiyama; Shinji Ueno; Soudai Kubota; Saki Okamoto; Yui Sakuramachi; Hitoshi Kuwata; Kouin Watanabe; Takanori Hyo; Chihiro Kouno; Satoko Hamasaki; Tomoko Menya; Hisako Noda; Naoki Hirose; Tomoko Okamoto; Hiroko Hashimoto; Yoshikazu Hirasawa; Tomoko Awa; Naomi Kitatani; Daisuke Yabe; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Oct. 2016

  
• Comparison of short-and long-acting glucagon-like peptide 1 receptor agonists on postprandial glucose excursion, insulin and glucagon secretions and gastric emptying

  Hitoshi Kuwata; Daisuke Yabe; Takeru Nagata; Sodai Kubota; Saki Okamoto; Shinji Ueno; Yui Sakuramachi; Koin Watanabe; Takanori Hyo; Nagaaki Tanaka; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Oct. 2016

  
• Original diabetes education programincluding individual self-care plan "My Goals Sheet" ameliorates long-term glycemic control in patients with diabetes mellitus

  Shinji Ueno; Nagaaki Tanaka; Takeru Nagata; Soudai Kubota; Saki Okamoto; Yui Sakuramachi; HItoshi Kuwata; Kouin Watanabe; Takanori Hyo; Chihiro Kouno; Satoko Hamasaki; Tomoko Menya; Mayuka Sakaguchi; Naomi Kitatani; Tomoko Okamoto; HIroko Hashimoto; Yoshikazu Hirasawa; Tomoko Awa; Daisuke Yabe; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Oct. 2016

  
• 低血糖クランプ法を用いた2型糖尿病患者での低血糖時におけるホルモン応答の評価 リナグリプチンおよびリラグリチドを用いた検討

  白源 正成; 矢部 大介; 江藤 隆; 入江 伸; 室谷 健太; 清野 佑介; 桑田 仁司; 黒瀬 健; 清野 進; Ahren Bo; 清野 裕

  臨床薬理, Oct. 2016

  
• 宿泊型新保健指導(Smart Life Stay)における体験型プログラムが生活習慣の変容に及ぼす効果

  佐野 喜子; 劉 大漫; 中村 誉; 安田 実加; 野村 恵里; 栄口 由香里; 松下 まどか; 村本 あき子; 矢部 大介; 小熊 祐子; 八谷 寛; 荒川 雅志; 樺山 舞; 津下 一代

  日本未病システム学会学術総会抄録集, Oct. 2016

  
• 海外文献紹介 p16(Ink4a)-Induced Senescence of Pancreatic Beta Cells Enhances Insulin Secretion

  龍岡久登; 矢部大介

  Diabetes Frontier, Oct. 2016, Invited

  
• 宿泊型新保健指導(スマート・ライフ・ステイ)プログラム(第2報) 肥満の有無別効果の検証

  松下 まどか; 栄口 由香里; 中村 誉; 加藤 綾子; 矢部 大介; 小熊 祐子; 佐野 喜子; 八谷 寛; 荒川 雅志; 村本 あき子; 津下 一代

  肥満研究, Sep. 2016

  
• インクレチン治療の最近の動向

  矢部大介; 桑田仁司; 清野裕

  BioClinica, Jul. 2016, Invited

  
• インクレチンと糖尿病食事療法

  桑田仁司; 矢部大介; 清野裕

  BioClinica, Jul. 2016, Invited

  
• Hormonal Responses during Hypoglycemia with Dipeptidyl Peptidase-4 Inhibitor Linagliptin and Glucagon-like Peptide-1 Receptor Agonist Liraglutide in Patients with Type 2 Diabetes

  Daisuke Yabe; Takashi Eto; Masanari Shiramoto; Shin Irie; Kenta Murotani; Yusuke Seino; Hitoshi Kuwata; Takeshi Kurose; Susumu Seino; Bo Ahren; Yutaka Seino

  DIABETES, Jun. 2016

  
• 糖尿病カンバセーション・マップ 6年の軌跡と未来

  矢部 大介; 原島 伸一; 東山 弘子; 清野 裕; 大部 正代; 中尾 友美

  DM Ensemble, May 2016

  
• Lecture note糖尿病と糖尿病

  矢部大介

  DxM, May 2016, Invited

  
• 宿泊型新保健指導プログラム その実施方法と進捗状況

  松下 まどか; 野村 恵里; 栄口 由香里; 加藤 綾子; 村本 あき子; 佐野 喜子; 樺山 舞; 小熊 祐子; 荒川 雅志; 八谷 寛; 矢部 大介; 津下 一代

  糖尿病, Apr. 2016

  
• DPP-4阻害薬は、グルカゴン欠損下では膵β細胞傷害時においても、GIPによるインスリン分泌増強を介して耐糖能を改善させる

  飯田 淳史; 清野 祐介; 前川 龍也; 村瀬 正敏; 矢部 大介; 清水 忍; 秋田 貴子; 恒川 新; 濱田 洋司; 林 良敬; 有馬 寛

  糖尿病, Apr. 2016

  
• 宿泊型新保健指導(スマート・ライフ・ステイ)

  村本 あき子; 松下 まどか; 栄口 由香里; 野村 恵里; 中村 誉; 矢部 大介; 小熊 祐子; 佐野 喜子; 樺山 舞; 八谷 寛; 荒川 雅志; 津下 一代

  臨床栄養, Mar. 2016

  
• CGMと精度管理

  矢部大介

  Diabetes Frontier, Mar. 2016, Invited

  
• インクレチン関連薬（DPP-4阻害薬、GLP-1受容体作動薬）

  岡本紗季; 矢部大介; 浜本芳之; 黒瀬健; 清野裕

  糖尿病の最新治療, Mar. 2016, Invited

  
• DPP-4 inhibitors and diabetes-related vascular complications

  矢部 大介

  医学のあゆみ, 27 Feb. 2016

  
• 林檎由来高分子および低分子プロシアニジン類長期投与による耐糖能への影響に関する検討

  長嶋一昭; 小倉かさね; 田原裕美子; 庄司俊彦; 小倉雅仁; 臼井亮太; 龍岡久登; 徳本信介; MUHAMMAD Fauzi; 矢部大介; 佐藤雄一; 杉崎和; 山野言; 佐藤広規; 稲垣暢也

  日本病態栄養学会誌(Web), 2016

  
• 新しい治療法、未来の糖尿病診療について

  脇 裕典; 野見山 崇; 矢部 大介; 平井 洋; 柴田 大河; 工藤 宏仁; 津村 和大

  さかえ: 月刊糖尿病ライフ, Jan. 2016

  
• 糖尿病の食事療法と低栄養への対応

  矢部大介

  ヒューマンニュートリション, 2016, Invited

  
• 糖尿病における栄養管理

  矢部大介; 清野裕

  BIOS, 2016, Invited

  
• GLP-1受容体作動薬追加のコツ

  桜町惟; 矢部大介; 清野裕

  medicina, 2016, Invited

  
• 食べる順番はどうしたらいいですか

  矢部大介

  ホルモンと臨床, 2016, Invited

  
• Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes : a randomised, controlled crossover, exploratory trial

  桑田仁司; 矢部大介; 清野裕

  Calm : approach to glycemic variations, 2016, Invited

  
• GLP-1の分泌制御と全身作用

  矢部大介

  日本臨床増刊号 新時代の臨床糖尿病学 上, 2016, Invited

  
• 未来のためにできること⑥治療中断予防策編

  矢部大介

  糖尿病ケア, 2016, Invited

  
• 糖尿病合併症って何？どうして糖尿病になると合併症になるの？

  矢部大介

  糖尿病ケア, 2016, Invited

  
• 日本糖尿病協会の糖尿病教育・支援ツールを活かす～質の高い療養指導の均てん化に向けて～

  矢部大介; 清野裕

  Diabetes Frontier, 2016, Invited

  
• 糖尿病食事療法における「食べる順番」の意義

  矢部大介; 桑田仁司; 清野裕

  Diabetes Journal –糖尿病と代謝–, 2016, Invited

  
• Reactive hypoglycemia

  桜町 惟; 矢部 大介; 黒瀬 健

  内分泌・糖尿病・代謝内科 = Endocrinology, diabetology & metabolism, Sep. 2015

  
• Use of the Japanese health insurance claims database to assess durability of DPP-4 inhibitors in patients with diabetes: comparison with other anti-diabetic drugs

  D. Yabe; H. Kuwata; R. Nishikino; M. Kaneko; C. Ito; K. Murotani; T. Kurose; Y. Seino

  DIABETOLOGIA, Sep. 2015

  
• CGMは糖尿病の血糖管理に有用か

  矢部大介; 大杉満; 松久宗英; 坂口一彦

  Journal of Diabetes Strategy, Aug. 2015

  
• 日本人糖尿病患者におけるDPP-4阻害薬と急性膵炎の関連性についての検討 健康保険データベースを用いた解析

  岡村 香織; 矢部 大介; 桑田 仁司; 金子 真紀子; 伊藤 千恵; 錦野 りえ; 室谷 健太; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2015

  
• 糖尿病教育のツールと学術集会

  矢部大介; 清野裕

  Diabetes Frontier, 2015, Invited

  
• 糖尿病・メタボリックシンドローム・脂質異常症

  岩崎真宏; 矢部大介; 清野裕

  内科, 2015, Invited

  
• インクレチン関連薬の位置づけと適正使用

  矢部大介; 清野裕

  医学のあゆみ, 2015, Invited

  
• インクレチンの膵外作用

  矢部大介; 清野裕

  最新医学 増刊号「糖尿病と合併症」, 2015, Invited

  
• Lecutre note 糖尿病治療と心理的サポート

  矢部大介

  DxM, 2015, Invited

  
• インクレチン製剤とインスリンの併用療法―メリットと注意点－

  矢部大介

  Diabetes Horizon, 2015, Invited

  
• 糖尿病診療を変革するインクレチン関連薬 –実臨床における実績と課題、そして今後の展望‐

  矢部大介

  Animus, 2015, Invited

  
• 糖尿病の薬物療法と食事療法のポイント

  矢部大介

  ヘルスケア・レストラン, 2015, Invited

  
• RISK FACTORS RESPONSIBLE FOR HYPOGLYCEMIA IN PATIENTS WITH DIABETES: A CROSS-SECTIONAL, SINGLE-CENTERED QUESTIONNAIRE-BASED STUDY

  Y. Sakuramachi; D. Yabe; H. Kuwata; K. Watanabe; T. Hyo; N. Tanaka; K. Takeshi; Y. Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Nov. 2014

  
• COMPARISON OF FISH OR MEAT INTAKE BEFORE AND AFTER RICE ON POSTPRANDIAL GLUCOSE EXCURSIONS AND INCRETIN SECRETION IN TYPE 2 DIABETES: MEAL-SEQUENCE AS A NOVEL TARGET IN DIETARY THERAPY FOR DIABETES

  H. Kuwata; D. Yabe; M. Iwasaki; R. Usui; K. Takeshi; Y. Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Nov. 2014

  
• COMPARISON OF POST-EXERCISE GLUCOSE EXCURSIONS AFTER USE OF INSULIN GLULISINE AND INSULIN ASPART IN PATIENTS WITH TYPE 2 DIABETES

  N. Tanaka; Y. Hiura; H. Kuwata; K. Watanabe; T. Hyo; D. Yabe; T. Kurose; Y. Seino

  DIABETES RESEARCH AND CLINICAL PRACTICE, Nov. 2014

  
• 「食べちゃダメ」だけでは逆効果!? 高度肥満を伴う糖尿病患者さん (特集 根拠があるから納得度UP! 専門医が答える困った症例解決塾) -- (食事療法について「困った!」)

  矢部 大介

  糖尿病ケア, Oct. 2014

  
• 糖尿病腎症の進行を食事でくい止めたいのです! ネフローゼ症候群になった糖尿病腎症の患者さん (特集 根拠があるから納得度UP! 専門医が答える困った症例解決塾) -- (食事療法について「困った!」)

  矢部 大介

  糖尿病ケア, Oct. 2014

  
• Meet the Expert : 巻頭インタビュー

  清野 裕; 矢部 大介

  Diabetes horizons : practice and progress = ダイアベーテスホライズンズ : プラクティスアンドプログレス, Jul. 2014

  
• Adjunctive Lixisenatide Treatment Improves Glycemic Control in Patients with T2DM Irrespective of beta-Cell Function

  Daisuke Yabe; Anu Ambos; Bertrand Cariou; Guillermo Gonzalez-Galvez; Yukio Ikeda; Donal O'Shea; Pedro De Pablos-Velasco; Lea Smircic-Duvnjak; Jean-Francois Yale; Marc Evans

  DIABETES, Jun. 2014

  
• Comparison of Fish or Meat Intake before and after Rice on Postprandial Glucose Excursions and Incretin Secretion in Type 2 Diabetes: Meal-Sequence As a Novel Target in Dietary Therapies for Diabetes

  Daisuke Yabe; Hitoshi Kuwata; Masahiro Iwasaki; Ryota Usui; Takeshi Kurose; Yutaka Seino

  ENDOCRINE REVIEWS, Jun. 2014

  
• GLP-1受容体作動薬のインスリンとの併用 GLP-1受容体作動薬のインスリンとの併用の要点について教えてください

  岡村香織; 矢部大介; 黒瀬健; 清野裕

  プラクティス, May 2014, Invited

  
• Meal sequence in medical nutrition therapies for individuals with type 2 diabetes

  矢部 大介

  ホルモンと臨床, Mar. 2014

  
• 糖尿病腎症の食事療法を考える ~たんぱく制限・塩分制限に対するPros, 塩分制限に対するCons, たんぱく制限に対するCons~

  矢部大介; 古家大祐; 古宮俊幸; 菅野義彦

  Diabetes Strategy, Feb. 2014, Invited

  
• DPP-4阻害薬、GLP-1受容体作動薬：治療成績と今後の展望

  矢部大介

  医薬ジャーナル, 2014, Invited

  
• Basic & Clinical TOPICS アジア人と非アジア人におけるDPP-4阻害薬の血糖降下作用の違い：システマティック・レビューとメタアナリシス

  矢部大介

  Diabetes Update, 2014, Invited

  
• 特集 日本人の糖尿病と欧米人の糖尿病 インクレチン分泌・作用」

  矢部大介; 清野裕

  ホルモンと臨床, 2014, Invited

  
• 学術集会ダイジェスト 職種間連携の象徴として

  津村和大; 矢部大介

  DM Ensemble, 2014, Invited

  
• DPP-4阻害薬、GLP-1受容体作動薬の安全性と懸念されている問題点

  矢部大介; 清野裕

  内科, 2014

  
• インクレチンと体重調節

  松本実紀; 矢部大介; 黒瀬健; 清野裕

  成人病と生活習慣病, 2014, Invited

  
• GLP-1受容体作動薬との併用

  矢部大介

  Pharma Medica, 2014, Invited

  
• Comment

  矢部大介

  Diabetes Care Japanese Edition, 2014, Invited

  
• ２型糖尿病をとりまく現状

  矢部大介; 清野裕

  ビオフィリア, 2014

  
• 糖尿病カンバセーション・マップTM

  黒瀬健; 矢部大介; 表孝徳

  糖尿病診療マスター, 2014, Invited

  
• GLP-1受容体作動薬はどのような患者に適していますか？

  臼井亮太; 矢部大介; 黒瀬健; 清野裕

  治療, 2014, Invited

  
• GLP-1受容体作動薬の種類と作用機序について教えてください

  六反麻里代; 矢部大介; 黒瀬健; 清野裕

  治療, 2014

  
• DPP-4阻害薬

  矢部大介

  Medical View Point, 2014, Invited

  
• DPP-4阻害薬と心血管イベントに関する臨床試験

  矢部大介; 清野裕

  Diabetes Journal, 2014

  
• 糖尿病の新しい薬物療法‐DPP-4阻害薬

  矢部大介; 清野裕

  Vita, 2014, Invited

  
• Lecture note 糖尿病腎症と透析予防

  矢部大介

  DxM, 2014, Invited

  
• IDF2013 第22回世界糖尿病会議

  桑田仁司; 矢部大介

  Diabetes Contempory, 2014, Invited

  
• 糖尿病薬物療法における低血糖回避の試み⁻最近の進歩②GLP-1受容体作動薬と低血糖

  松本実紀; 矢部大介; 黒瀬健; 清野裕

  Diabetes Frontier, 2014, Invited

  
• 糖尿病治療の新展開～インクレチンから次世代糖尿病薬まで～

  矢部大介

  奈良県医師会医学年報, 2014, Invited

  
• 専門医が答える困った症例解決塾 ４ 食事療法について困った！

  矢部大介

  糖尿病ケア, 2014, Invited

  
• 日本糖尿病協会を知る：教育と医療連携にいかす

  矢部大介

  DM Ensemble, 2014, Invited

  
• DPP-4阻害薬のインパクト － 糖尿病治療はどのように変わったか？

  矢部大介; 清野裕

  日本医事新報, 2014, Invited

  
• 消化管ペプチドと代謝制御

  矢部大介

  内分泌・糖尿病・代謝内科, 2014, Invited

  
• インクレチンと体重調節 (特集 インクレチン関連薬による糖尿病治療の新時代) -- (糖代謝以外のインクレチン関連薬のもつ多彩な作用)

  松本 実紀; 矢部 大介; 黒瀬 健

  成人病と生活習慣病 : 日本成人病(生活習慣病)学会準機関誌, Dec. 2013

  
• Efficacy of lixisenatide in patients with different levels of beta cell function as assessed by C-peptide/glucose ratio

  J. J. Meier; D. Yabe; E. Wang; J. Lin; J. Rosenstock; B. Ahren

  DIABETOLOGIA, Sep. 2013

  
• 土-3-S6-2 糖尿病透析予防指導におけるチーム医療の取り組み(糖尿病透析予防指導で薬剤師が求められているスキル,シンポジウム6,再興、再考、創ろう最高の医療の未来)

  岩崎 真宏; 北谷 直美; 安原 章浩; 矢部 大介; 黒瀬 健; 清野 裕

  日本医療薬学会年会講演要旨集, 28 Aug. 2013

  
• DPP-4阻害薬の各薬剤間に差はあるのか

  稲垣暢也; 綿田裕孝; 植木浩二郎; 山田祐一郎; 矢部大介

  Diabetes Strategy, Aug. 2013, Invited

  
• 糖尿病専門医に役立つ臨床トピックス インクレチン製剤とインスリンの併用療法 : メリットと注意点

  矢部 大介

  Diabetes horizons : practice and progress = ダイアベーテスホライズンズ : プラクティスアンドプログレス, Jul. 2013

  
• Pathophysiology of Type 2 Diabetes and Efficacy of Incretin-related Drugs

  矢部 大介; 清野 裕

  最新医学, Jun. 2013

  
• ヒト甲状腺におけるglucagon-like peptide-1受容体の発現

  岩崎真宏; 矢部大介; 清野裕

  Diabetes Strategy, Feb. 2013, Invited

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第18回 トピックス

  矢部大介

  さかえ, Feb. 2013, Invited

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第17回 トピックス

  矢部大介

  さかえ, Jan. 2013, Invited

  
• 糖尿病カンバセーション・マップTMを活用 糖尿病療養支援におけるパラダイムシフト

  矢部大介

  Nursing Business, 2013, Invited

  
• 第9回IDF-WPR会議/第4回AASD学術集会 開催報告

  矢部大介; 清野裕

  DM Ensemble, 2013, Invited

  
• Comment

  矢部大介; 清野裕

  Diabetes Care Japanese Edition, 2013, Invited

  
• DPP-4阻害薬

  矢部大介; 清野裕

  Medical Practice, 2013, Invited

  
• Incretin and diet

  矢部大介; 岩崎真宏; 北谷直美; 黒瀬健; 清野裕

  内分泌・糖尿病・代謝内科, 2013, Invited

  
• 西太平洋地区における糖尿病カンバセーション・マップTMの動向－第９回IDF-WPR会議/第4回AASD学術集荷ワークショップの報告－

  矢部大介; 清野裕

  DM Ensemble, 2013, Invited

  
• 糖尿病の病態とインクレチン関連薬の臨床効果

  矢部大介

  最新医学, 2013, Invited

  
• 糖尿病治療併用療法を極める インクレチン関連薬＋α 第4章インスリンとの併用療法－こんな症例に最適＆こんな症例には×

  矢部大介

  週刊日本医事新報, 2013, Invited

  
• 糖尿病カンバセーション・マップTM グループ体験から始める糖尿病の療養

  矢部大介

  看護技術, 2013, Invited

  
• インクレチン製剤とインスリンの併用療法－メリットと注意点－

  矢部大介

  Diabetes Horizons, 2013, Invited

  
• 糖尿病は家族にとっても大きな心理的不安となる‐DAWN2研究の結果報告から‐

  矢部大介

  OneTouch Forward, 2013, Invited

  
• 経口血糖降下薬における位置づけ

  矢部大介

  糖尿病, 2013, Invited

  
• インクレチンと血糖管理①栄養素によるインクレチン分泌制御

  矢部大介; 清野裕

  Diabetes Frontier, 2013, Invited

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第16回 トピックス

  矢部大介

  さかえ, Dec. 2012, Invited

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第15回 トピックス

  矢部大介

  さかえ, Nov. 2012, Invited

  
• Dietary intake and serum level of n-3 polyunsaturated fatty acids as predictors of DPP-4 inhibitor efficacy in patients with type 2 diabetes

  M. Iwasaki; D. Yabe; F. Hoshian; T. Tsuji; N. Hirose; T. Matsumoto; N. Kitatani; K. Sugawara; R. Usui; H. Kuwata; S. Fujiwara; K. Watanabe; T. Hyo; T. Kurose; Y. Seino

  DIABETOLOGIA, Oct. 2012

  
• Metformin enhances secretion of GLP-1 but not GIP and improves postprandial glucose excursion in Japanese patients with type 2 diabetes

  H. Kuwata; D. Yabe; K. Sugawara; R. Usui; K. Sugizaki; Y. Kitamoto; S. Fujiwara; K. Watanabe; T. Hyo; T. Murakami; T. Yamaguchi; S. Shimizu; H. Eto; T. Kurose; Y. Seino

  DIABETOLOGIA, Oct. 2012

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第15回 トピックス

  矢部大介

  さかえ, Oct. 2012

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第14回 トピックス

  矢部大介

  さかえ, Oct. 2012, Invited

  
• 糖尿病療養指導における新しい学習ツール「カンバセーションマップ」の取組みと効果の検討

  北谷直美; 岩崎真宏; 東山弘子; 矢部大介; 横田香世; 小倉雅仁; 原島伸一; 辻とも子; 黒瀬健; 清野裕

  糖尿病, Sep. 2012

  
• 糖尿病ケトアシドーシス昏睡で発症した脳膿瘍の1例

  藤原 周一; 表 孝徳; 黒瀬 健; 臼井 亮太; 菅原 健二; 北本 友佳; 杉崎 和; 桑田 仁司; 渡邊 好胤; 矢部 大介; 清野 裕

  糖尿病, Sep. 2012

  
• シタグリプチン服用中に自己免疫性膵炎を発症した高齢2型糖尿病患者の1例

  渡邊 好胤; 菅原 健二; 表 孝徳; 矢部 大介; 東 恵史朗; 染田 仁; 黒瀬 健; 中村 武史; 清野 裕

  糖尿病, Sep. 2012

  
• 糖尿病患者におけるFMD測定値に関与する因子の検討

  黒瀬 健; 杉崎 和; 菅原 健二; 桑田 仁司; 藤原 周一; 北本 友佳; 臼井 亮太; 渡辺 好胤; 表 孝徳; 矢部 大介; 清野 裕

  糖尿病, Sep. 2012

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第13回 トピックス

  矢部大介

  さかえ, Sep. 2012, Invited

  
• 薬物未治療もしくは経口糖尿病薬治療中の2型糖尿病患者へのリラグルチド導入の効果

  矢部 大介; 臼井 亮太; 菅原 健二; 北本 友佳; 杉崎 和; 藤原 周一; 渡邊 好胤; 表 孝徳; 安原 章浩; 黒瀬 健; 清野 裕

  糖尿病, Aug. 2012

  
• 日本人2型糖尿病患者のインクレチン分泌パターンの特徴と分泌に影響を与える因子の検索

  桑田 仁司; 矢部 大介; 臼井 亮太; 菅原 健二; 北本 友佳; 杉崎 和; 藤原 周一; 渡邊 好胤; 表 孝徳; 黒瀬 健; 清野 裕

  糖尿病, Aug. 2012

  
• インスリンからリラグルチドへの変更時の効果及び注意点に関する検討

  臼井 亮太; 矢部 大介; 菅原 健二; 北本 友佳; 桑田 仁司; 杉崎 和; 藤原 周一; 渡辺 好胤; 表 孝徳; 黒瀬 健; 清野 裕

  糖尿病, Aug. 2012

  
• リラグルチド導入による血糖日内変動の改善 持続血糖測定(CGM)と1,5-AGによる評価

  杉崎 和; 矢部 大介; 臼井 亮太; 菅原 健二; 北本 友佳; 桑田 仁司; 藤原 周一; 渡邊 好胤; 表 孝徳; 黒瀬 健; 清野 裕

  糖尿病, Aug. 2012

  
• ペグインターフェロンによる慢性C型肝炎治療後に発症した1型糖尿病の1例

  北本 友佳; 矢部 大介; 菅原 健二; 桑田 仁司; 杉崎 和; 藤原 周一; 渡邊 好胤; 表 孝徳; 黒瀬 健; 清野 裕

  糖尿病, Aug. 2012

  
• 糖尿病治療はどのように何からはじめるか~単剤療法, 併用療法, 強化インスリン療法~

  矢部大介; 遅野井健; 柱本満; 鈴木大輔; 俵本和仁; 豊田雅夫; 吉井秀徳

  Diabetes Strategy, Aug. 2012, Invited

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第11回 トピックス

  矢部大介

  さかえ, Jul. 2012, Invited

  
• Evaluation of Diabetic Neuropathy Using Pupillary Light Reflex Test in Patients With Diabetes Mellitus

  Takeshi Kurose; Shuuichi Fujiwara; Koin Watanabe; Takanori Hyo; Daisuke Yabe; Yutaka Seino

  DIABETES, Jun. 2012

  
• Incretin secretion and action : Comparison between Japanese and Caucasians

  矢部 大介; 清野 裕

  ホルモンと臨床, May 2012

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第10回 トピックス

  矢部大介

  さかえ, May 2012, Invited

  
• インスリンからリラグルチドへの変更時の効果および注意点に関する検討

  臼井 亮太; 矢部 大介; 菅原 健二; 桑田 仁司; 藤原 周一; 北本 友佳; 杉崎 和; 渡邊 好胤; 表 孝徳; 安原 章浩; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2012

  
• 瞳孔反応を用いた糖尿病神経障害の評価 糖尿病自律神経障害早期検出のためのカットオフ値の検討

  藤原 周一; 矢部 大介; 黒瀬 健; 菅原 健二; 臼井 亮太; 北本 友佳; 杉崎 和; 桑田 仁司; 渡邊 好胤; 表 孝徳; 清野 裕

  糖尿病, Apr. 2012

  
• シタグリプチン投与時のSU薬とメトホルミンの影響

  桑田 仁司; 臼井 亮太; 菅原 健二; 北本 友佳; 杉崎 和; 藤原 周一; 渡邊 好胤; 表 孝徳; 安原 章浩; 矢部 大介; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2012

  
• DPP-4阻害薬の血糖改善効果に影響する摂取および血中栄養素

  岩崎 真宏; 矢部 大介; 星庵 史典; 辻 とも子; 廣瀬 直樹; 松元 知子; 北谷 直美; 菅原 健二; 臼井 良太; 桑田 仁; 杉崎 和; 北本 友佳; 渡邊 好胤; 藤原 周一; 表 孝徳; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2012

  
• 2型糖尿病患者におけるFMD値の検討について

  渡邊 好胤; 黒瀬 健; 菅原 健二; 臼井 亮太; 藤原 周一; 北本 友佳; 桑田 仁司; 杉崎 和; 表 孝徳; 安原 章浩; 矢部 大介; 福島 光夫; 清野 裕

  糖尿病, Apr. 2012

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第9回 トピックス

  矢部大介

  さかえ, Apr. 2012, Invited

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第7回 トピックス

  矢部大介

  さかえ, Feb. 2012, Invited

  
• インクレチンと糖尿病－臨床研究の発展－

  矢部大介

  メディカルビューポイント, 2012, Invited

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－第6回 糖尿病の療養とストレス

  矢部大介

  さかえ, Jan. 2012, Invited

  
• インクレチンの臨床科学

  矢部大介

  西宮市医師会医学雑誌, 2012, Invited

  
• 学会レポート AASD2011

  矢部大介

  糖尿病の最新治療, 2012, Invited

  
• DPP-4阻害薬から学ぶSU薬の適正使用

  矢部大介; 清野裕

  medicina, 2012, Invited

  
• 「糖尿病カンバセーション・マップTM」の目指すもの

  矢部大介

  DM Ensemble, 2012, Invited

  
• インクレチン関連薬と食事療法

  岩崎真宏; 矢部大介; 清野裕

  DM Ensemble, 2012, Invited

  
• 栄養素によるインクレチン分泌の制御機構

  矢部大介; 岩崎真宏; 清野裕

  内分泌・糖尿病・代謝内科, 2012, Invited

  
• インクレチン関連薬の現状と展望

  矢部大介; 清野裕

  Modern Physician, 2012, Invited

  
• グループ体験からはじめる糖尿病

  矢部大介; 東山弘子

  DM Ensemble, 2012, Invited

  
• 糖尿病カンバセーション・マップTM グループ体験を取り入れた糖尿病療養指導の始まり

  矢部大介; 東山弘子

  メディカル朝日, 2012, Invited

  
• 糖尿病カンバセーション・マップTM－グループ体験を取り入れた糖尿病療養指導のはじまり

  矢部大介; 東山弘子

  Diabetes Journal (糖尿病と代謝), 2012, Invited

  
• 糖尿病地域連携の現状と今後の展開

  矢部大介

  メディカルビューポイント, 2012, Invited

  
• ４．インクレチンに関する最近の話題 １）インクレチンを考慮した食事療法

  岩崎真宏; 矢部大介; 北谷直美; 黒瀬健; 清野裕

  Progress in Medicine, 2012, Invited

  
• ２．インクレチン関連薬の現状と課題：安全性と有効性を探る ２）血糖コントロールにおける長期効果

  矢部大介; 清野裕

  Progress in Medicine, 2012, Invited

  
• DPP-4阻害薬の有効性を高める食事療法・運動療法の確立に向けて

  矢部大介

  薬事日報, 2012, Invited

  
• DPP-4阻害薬の有効性を高める食事・運動療法

  矢部大介

  メディカル朝日, 2012, Invited

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－ 第4回 糖尿病Q&A

  矢部大介

  さかえ, Nov. 2011, Invited

  
• Effects of sitagliptin, acarbose and sulfonylureas on postprandial levels of GLP-1 and GIP in Japanese patients with type 2 diabetes

  D. Yabe; K. Watanabe; K. Sugawara; H. Kuwata; Y. Kitamoto; K. Sugizaki; S. Fujiwara; M. Hishizawa; T. Hyo; K. Kuwabara; K. Yokota; M. Iwasaki; N. Kitatani; T. Kurose; Y. Seino

  DIABETOLOGIA, Sep. 2011

  
• Effect of different anatomical changes in gastrointestinal anatomy on glycaemic control after surgery in type 2 diabetic patients with early gastric cancer

  T. Kurose; T. Hyo; K. Watanabe; S. Fujiwara; H. Kuwata; K. Sugizaki; Y. Kitamoto; D. Yabe; Y. Seino

  DIABETOLOGIA, Sep. 2011

  
• 血糖コントロールの指標はなにが有用か~CGM, SMBG, 1,5AG~

  山田祐一郎; 西村理明; 渥美義仁; 山内俊一; 及川洋一; 神田順二; 辻野大助; 矢部大介

  Diabetes Strategy, Aug. 2011, Invited

  
• 睡眠呼吸障害に関与する因子 肥満度及び血糖コントロールについて

  北本 友佳; 矢部 大介; 菅原 健二; 桑田 仁司; 杉崎 和; 藤原 周一; 渡邊 好胤; 菱澤 方洋; 表 孝徳; 丸本 圭一; 立花 直子; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2011

  
• 瞳孔反応を用いた糖尿病神経障害の評価 既存神経障害関連検査との相関とカットオフ値の検討

  藤原 周一; 矢部 大介; 菅原 健二; 北本 友佳; 杉崎 和; 桑田 仁司; 渡邊 好胤; 表 孝徳; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2011

  
• 糖尿病治療法選択時点における治療法と細小血管障害重症度との関連

  杉崎 和; 黒瀬 健; 菅原 健二; 北本 友佳; 桑田 仁司; 藤原 周一; 渡邊 好胤; 表 孝徳; 矢部 大介; 清野 裕

  糖尿病, Apr. 2011

  
• リラグルチド使用中の2型糖尿病患者の食事調査 リラグルチド開始前後の比較検討

  北谷 直美; 辻 とも子; 岩崎 真宏; 北本 友佳; 杉崎 和; 桑田 仁司; 藤原 周一; 菅原 健二; 渡邊 好胤; 表 孝徳; 矢部 大介; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2011

  
• DPP-4阻害薬の血糖改善効果をより効果的にする食事療法

  岩崎 真宏; 北谷 直美; 矢部 大介; 辻 とも子; 渡邊 好胤; 表 孝徳; 北本 友香; 杉崎 和; 桑田 仁司; 藤原 周一; 菅原 健二; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2011

  
• SU薬の併用がシタグリプチンの効果に変化を与えるか否かの検討

  桑田 仁司; 黒瀬 健; 杉崎 和; 北本 友佳; 菅原 健二; 藤原 周一; 渡邊 好胤; 表 孝徳; 福島 光夫; 北谷 直美; 矢部 大介; 清野 裕

  糖尿病, Apr. 2011

  
• 糖尿病を伴う胃癌患者における外科手術再建法の違いによる血糖コントロールへの影響についての検討

  表 孝徳; 黒瀬 健; 菅原 健二; 桑田 仁司; 藤原 周一; 杉崎 和; 北本 友佳; 渡邊 好胤; 矢部 大介; 粟根 雅章; 清野 裕

  糖尿病, Apr. 2011

  
• インスリンからリラグルチドへの治療変更に関する適応と有効性の検討

  矢部 大介; 菅原 健二; 桑田 仁司; 北本 友佳; 杉崎 和; 藤原 周一; 渡邊 好胤; 表 孝徳; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2011

  
• 当院における糖尿病地域連携パスを用いた患者の血糖コントロールの特徴について

  渡邊 好胤; 矢部 大介; 北谷 直美; 菅原 健二; 北本 友佳; 桑田 仁司; 杉崎 和; 藤原 周一; 菱澤 方洋; 表 孝徳; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2011

  
• シタグリプチン投与によりインスリン離脱が出来た糖尿病患者11例の検討

  藤原 周一; 黒瀬 健; 杉崎 和; 北本 友佳; 菅原 健二; 桑田 仁司; 渡辺 好胤; 表 孝徳; 福島 光夫; 矢部 大介; 清野 裕

  糖尿病, Mar. 2011

  
• 糖尿病患者におけるシタグリプチン併用時の薬物減量の影響について

  桑田 仁司; 黒瀬 健; 杉崎 和; 北本 友佳; 菅原 健二; 藤原 周一; 渡辺 好胤; 表 孝徳; 福島 光夫; 矢部 大介; 清野 裕

  糖尿病, Mar. 2011

  
• 浮腫・貧血を契機に、低栄養を伴う著明な膵萎縮・慢性膵炎が判明した糖尿病の一例

  安田 慎吾; 渡邊 好胤; 菅原 健二; 北本 友佳; 杉崎 和; 藤原 周一; 桑田 仁司; 表 孝徳; 矢部 大介; 黒瀬 健; 清野 裕

  糖尿病, Mar. 2011

  
• 繰り返す自己中断によりインスリン依存状態に至った2型糖尿病患者の一例

  八木 久実; 矢部 大介; 菅原 健二; 北本 友佳; 桑田 仁司; 杉崎 和; 藤原 周一; 渡邊 好胤; 表 孝徳; 黒瀬 健; 清野 裕

  糖尿病, Mar. 2011

  
• 口腔内感染症が敗血症の原因と考えられる2型糖尿病の一例

  北本 友佳; 渡邊 好胤; 矢部 大介; 杉崎 和; 沖野 巌; 菅原 健二; 菱澤 方洋; 表 孝徳; 福島 光夫; 黒瀬 健; 清野 裕

  糖尿病, Mar. 2011

  
• 自己中断歴を有し糖尿病性ケトアシドーシス(DKA)と肺炎球菌性肺炎を合併した一例

  渡邊 好胤; 北本 友佳; 菅原 健二; 杉崎 和; 藤原 周一; 桑田 仁司; 表 孝徳; 矢部 大介; 黒瀬 健; 清野 裕

  糖尿病, Mar. 2011

  
• GAD抗体高値を示しながらインスリン分泌能が保持された橋本病合併の1型糖尿病の一例

  表 孝徳; 田中 正代; 菅原 健二; 桑田 仁司; 藤原 周一; 杉崎 和; 北本 友佳; 渡邊 好胤; 矢部 大介; 黒瀬 健; 清野 裕

  糖尿病, Mar. 2011

  
• インクレチンは何を壊し何を創ったのか

  清野裕; 稲垣暢也; 綿田裕孝; 矢部大介; 植木浩二郎; 山田祐一郎

  Diabetes Strategy, Feb. 2011, Invited

  
• Interview Rising Star

  矢部大介

  Diabetes Strategy, Feb. 2011, Invited

  
• インクレチン関連薬の選択と使い方

  矢部大介; 清野裕

  Medical Practice, 2011, Invited

  
• インクレチン分泌のメカニズム

  矢部大介

  最新医学, 2011, Invited

  
• 糖尿病カンバセーション・マップTM －話し合いを通して糖尿病について学ぶ、新しい発見学習教材－

  矢部大介

  さかえ, 2011, Invited

  
• 大阪地域における糖尿病連携パスの実践と成果

  矢部大介; 清野裕

  Diabetes Frontier, 2011, Invited

  
• インクレチンの測定法とその問題点

  矢部大介

  日本臨床, 2011, Invited

  
• インクレチンのここがわからない！？

  矢部大介; 清野裕

  Journal of Diabetes Strategy, 2011, Invited

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－ 第１回

  矢部大介

  さかえ, 2011, Invited

  
• インクレチン分泌-αグリコシダーゼ阻害薬とメトホルミンの作用を含め

  矢部大介; 清野裕

  Progress in Medicine, 2011, Invited

  
• DPP-4阻害薬は血糖変動幅を小さくするのでしょうか？

  矢部大介; 清野裕

  糖尿病レクチャー, 2011, Invited

  
• 質疑応答：GLP-1の血中動態について

  矢部大介; 清野裕

  日本医事新報, 2011, Invited

  
• インクレチンの臨床科学

  矢部大介

  循環プラス, 2011, Invited

  
• 連載 糖尿病カンバセーション・マップ－話し合いを通して糖尿病について学ぶ－ 第3回 糖尿病Q&A

  矢部大介

  さかえ, 2011, Invited

  
• 大阪地域における糖尿病地域連携の現状とこれから－日本糖尿病協会編「糖尿病連携手帳」の活用―

  矢部大介

  大阪府内科医会会誌, 2011, Invited

  
• わが国におけるDPP-4阻害薬の臨床‐臨床応用2年を経て－

  黒瀬健; 表孝徳; 渡辺好胤; 矢部大介; 清野裕

  糖尿病の最新治療, 2011, Invited

  
• インクレチン測定の標準化

  矢部大介; 清野裕

  Diabetes Journal (糖尿病と代謝), 2011, Invited

  
• ディベート コメント

  矢部大介

  Journal of Diabetes Strategy, 2011, Invited

  
• 糖尿病と口腔ケア

  黒瀬健; 表孝徳; 渡邊好胤; 杉崎和; 北本友佳; 桑田仁司; 藤原周一; 臼井亮太; 菅原健二; 安原章浩; 矢部大介; 清野裕

  関西電力病院医学雑誌, 2011

  
• 糖尿病カンバセーションマップ

  小倉雅仁; 矢部大介; 東山弘子; 原島伸一; 山田千積; 北谷直美; 清野裕; 稲垣暢也

  月刊内分泌・糖尿病・代謝内科, Dec. 2010

  
• O12-10 新規糖尿病薬DPP-4阻害薬シタグリプチンの有用性について(一般演題 口頭発表,糖尿病,臨床から学び臨床へと還元する医療薬学)

  岡本 朋子; 上田 浩貴; 塚本 康彦; 矢部 大介; 黒瀬 健; 濱口 良彦; 清野 裕

  日本医療薬学会年会講演要旨集, 25 Oct. 2010

  
• 糖尿病治療法選択時点における治療法と細小血管障害重症度との関連

  杉崎 和; 黒瀬 健; 菅原 健二; 北本 友佳; 藤原 周一; 桑田 仁司; 渡邊 好胤; 表 孝徳; 矢部 大介; 清野 裕

  糖尿病合併症, Oct. 2010

  
• 糖尿病連携手帳 ～糖尿病の療養の新たなパートナーとして～

  矢部大介

  さかえ, Oct. 2010, Invited

  
• GIP receptor polymorphism rs10423928 affects body mass index and insulin and glucagon response after ingestion of glucose or mixed meals in Japanese

  D. Yabe; K. Watanabe; Y. Kitamoto; K. Sugizaki; K. Sugawara; M. Hishizawa; T. Hyo; T. Kurose; Y. Seino

  DIABETOLOGIA, Sep. 2010

  
• 日本人糖尿病におけるインクレチン治療の有効性 (特集 インクレチンの臨床:2型糖尿病の新しい治療--2型糖尿病におけるインクレチン関連薬の可能性)

  矢部 大介; 清野 裕

  糖尿病, Jun. 2010

  
• 血中C-ペプチドと糖尿病細小血管障害との関連について

  杉崎 和; 黒瀬 健; 矢部 大介; 表 孝徳; 菱澤 方洋; 渡邊 好胤; 北本 友佳; 菅原 健二; 清野 裕

  糖尿病, Apr. 2010

  
• 日本人超早期インスリン分泌を規定する遺伝学的因子の検討

  北本 友佳; 矢部 大介; 渡辺 好胤; 沖野 巌; 杉崎 和; 菅原 健二; 菱澤 方洋; 表 孝徳; 大串 美奈子; 大屋 道洋; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2010

  
• ヒト血漿中の活性型GLP-1濃度の測定法に関する検討

  矢部 大介; 渡辺 好胤; 沖野 巌; 北本 友佳; 杉崎 和; 菅原 健二; 菱澤 方洋; 表 孝徳; 橋本 勉; 飯野 由加里; 酒井 千菜; 黒瀬 健; 清野 裕

  糖尿病, Apr. 2010

  
• 糖尿病性足壊疽による敗血症をきたしたが、保存的治療にて改善した一例

  村上 永尚; 矢部 大介; 渡邊 好胤; 表 孝徳; 菱沢 方洋; 杉崎 和; 北本 由佳; 大串 美奈子; 大屋 道洋; 黒瀬 健; 清野 裕

  糖尿病, Feb. 2010

  
• ミトコンドリアDNA3243変異を有するミトコンドリア糖尿病の一例

  北本 友佳; 矢部 大介; 渡邊 好胤; 菱澤 方洋; 表 孝徳; 大屋 道洋; 大串 美奈子; 杉崎 和; 菅原 健二; 黒瀬 健; 清野 裕

  糖尿病, Feb. 2010

  
• 糖尿病地域連携パス 関西電力病院における取り組みと今後の課題

  矢部 大介; 渡邊 好胤; 菱澤 方洋; 表 孝徳; 北谷 直美; 北本 由佳; 杉崎 和; 沖野 巌; 菅原 健二; 黒瀬 健; 清野 裕

  糖尿病, Feb. 2010

  
• グルカゴンの奇異性分泌亢進を認めた劇症1型糖尿病の一例

  菅原 健二; 矢部 大介; 渡邊 好胤; 菱澤 方洋; 表 孝徳; 大屋 道洋; 黒江 彰; 大串 美奈子; 奥 正之; 黒瀬 健; 清野 裕

  糖尿病, Feb. 2010

  
• 血中C-ペプチドと糖尿病細小血管障害との関連について

  杉崎 和; 黒瀬 健; 矢部 大介; 北本 友佳; 菅原 健二; 渡邊 好胤; 菱澤 方洋; 表 孝徳; 清野 裕

  糖尿病, Feb. 2010

  
• 日本の糖尿病研究と治療：これまでとこれからの10年

  清野裕; 稲垣暢也; 植木浩二郎; 山田祐一郎; 綿田裕孝; 矢部大介

  Journal of Diabetes Strategy, Feb. 2010

  
• 糖尿病の療養指導Q&Aインクレチン関連薬の安全性

  矢部大介; 清野裕

  PRACTICE, 2010, Invited

  
• EDITORIAL: 日本糖尿病協会『糖尿病連携手帳』～大阪から全国へ～

  矢部大介; 朴孝憲; 武田純

  DITN, Jan. 2010, Invited

  
• 日本糖尿病協会『糖尿病連携手帳』～糖尿病地域連携のこれから～

  矢部大介

  メディカルビューポイント, 2010, Invited

  
• Incretin-based drugs: DPP-4 inhibitors and GLP-1 receptor agonists

  矢部大介; 清野裕

  Endocrinology, diabetology & metabolism, 2010, Invited

  
• インクレチン研究と臨床における治療応用

  清野裕; 矢部大介; 菅原健二; 北本友佳; 桑田仁司; 杉崎和; 藤原周一; 渡邊好胤; 表孝徳; 黒瀬健

  関西電力病院医学雑誌, 2010, Invited

  
• インクレチン測定標準化に向けて

  矢部大介; 清野裕

  Medical Science Digest, 2010, Invited

  
• 日本人におけるインクレチン治療の有効性：日本人のインクレチン血中濃度を踏まえて

  矢部大介; 清野裕

  月刊 糖尿病, 2010, Invited

  
• 糖尿病におけるインクレチン血中動態とインスリン分泌促進作用‐日本人のインクレチン血中濃度を踏まえて

  矢部大介; 清野裕

  医学のあゆみ, 2010, Invited

  
• インクレチン- GLP-1及びGIP -

  矢部大介; 清野裕

  Diabetes Frontier, 2010, Invited

  
• AASD (The Asian Association for the Study of Diabetes) 発足と将来展望

  矢部大介; 清野裕

  Diabetes Journal –糖尿病と代謝–, 2010

  
• Incretin-based therapeutics: benefits and potential cautions for Japanese patients with type 2 diabetes

  矢部 大介; 清野 裕

  International review of diabetes, Oct. 2009

  
• The clinical science of incretin

  黒瀬 健; 矢部 大介; 表 孝徳

  International review of diabetes, Oct. 2009

  
• No enhancement of meal-induced GLP-1 secretion and reduced intact GLP-1 levels in Japanese patients with type 2 diabetes as well as healthy controls

  D. Yabe; A. Kuroe; S. Lee; C. F. Deacon; K. Watanabe; T. Hyo; M. Hishizawa; T. Kurose; J. J. Holst; T. Hirano; N. Inagaki; Y. Seino

  DIABETOLOGIA, Sep. 2009

  
• インクレチンの概念と研究の歴史－GIPとGLP-1の発見から糖尿病治療への臨床応用に至るまで

  矢部大介; 清野裕

  医学のあゆみ, Jul. 2009, Invited

  
• Detection of Coronary Artery Disease with the Use of 2-Dimensional Speckle-Tracking Echocardiography in Patients with DM

  Takeshi Kurose; Katsuhisa Ishli; Takanori Hyou; Koin Watanabe; Masahiro Hishizawa; Daisuke Yabe; Akira Kuroe; Yutaka Seino

  DIABETES, Jun. 2009

  
• インクレチンのClinical Science

  黒瀬健; 矢部大介; 清野裕

  International Review of Diabetes, 2009, Invited

  
• 我が国におけるインクレチン関連薬の可能性と問題点

  矢部大介; 清野裕

  International Review of Diabetes, 2009, Invited

  
• 糖尿病地域連携パスを活用した糖尿病管理のこれから

  矢部大介

  大阪府内科医会会報, 2009, Invited

  
• ２型糖尿病におけるアディポサイトカインの役割 ‐内分泌器官としての脂肪組織‐

  矢部大介; 黒瀬健; 清野裕

  PRACTICE, 2009, Invited

  
• 膵特異Rbp-jノックアウトマウスの検討

  藤倉 純二; 細田 公則; 川口 義弥; 野口 倫生; 岩倉 浩; 冨田 努; 小鳥 真司; 森 栄作; 泰江 慎太郎; 石井 崇子; 岡田 定規; 日下部 徹; 平田 雅一; 海老原 健; 益崎 裕章; 谷垣 健二; 矢部 大介; 中尾 一和

  日本内分泌学会雑誌, Apr. 2008

  
• 膵特異的Rbp-jノックアウトマウスの検討

  藤倉 純二; 細田 公則; 川口 義弥; 野口 倫生; 岩倉 浩; 冨田 努; 小島 真司; 森 栄作; 泰江 慎太郎; 石井 崇子; 岡田 定規; 日下部 徹; 平田 雅一; 海老原 健; 益崎 裕章; 谷垣 健二; 矢部 大介; 中尾 一和

  糖尿病, Apr. 2008

  
• 急増する糖尿病患者とメタボリック・シンドロームの“落とし穴”

  清野裕; 矢部大介

  岩波書店 科学, 2008, Invited

  
• インクレチン・ホルモン：2型糖尿病治療の新展開

  矢部大介; 黒江章; 黒瀬健; 清野裕

  ホルモンと臨床, 2008, Invited

  
• Notchシグナルによる細胞分化制御:シグナルの不活化と過剰活性化を可能にする2種類の遺伝子欠損マウスの比較解析からわかったこと

  矢部大介; 福田仁; 青木節代; 竹林慎治; 山本典生; 本庶佑

  日本薬学会年会要旨集, 05 Mar. 2007

  
• Notchシグナルを負に制御する因子Mintによる神経発生の制御

  福田仁; 矢部大介; 山田秀一; 辻正幸; 竹林慎治; 山本典生; 新蔵礼子; 高橋淳; 橋本信夫; 真貝洋一; 本庶佑

  日本脳神経外科学会総会抄録集(CD-ROM), 2005

  
• T細胞分化におけるMINTの機能解析

  辻正幸; 新蔵礼子; 矢部大介; 山本典生; 本庶佑

  日本免疫学会総会・学術集会記録, 05 Nov. 2004

  
• HIV-1耐性遺伝子の研究

  田代啓; 池川雅哉; 矢部大介; 本庶佑

  日本臨牀, Apr. 1999, Invited

  
• Anti-HIV-1 genes; genetic restriction of AIDS pathogenesis by gene variants

  K. Tashiro; M. Ikegawa; D. Yabe; T. Honjo

  Nippon rinsho. Japanese journal of clinical medicine, 01 Jan. 1999

  
• Raising Anti‐SDF‐1 Antibodies and SDF‐1 Protein Characterization.

  田代啓; 池川雅哉; 矢部大介; 谷垣健二; 中野伊知郎; 中むら智之; 小夫家和宏; 本庶佑

  日本分子生物学会年会プログラム・講演要旨集, Dec. 1997

  
• Molecular cloning and characterization of a novel cytokine obtained from the murine embryonic heart

  T Nakamura; D Yabe; T Honjo

  CIRCULATION, Oct. 1997

  
• 0822 発生期マウス心臓からの新たなサイトカインのクローニング : yeastを用いた新シグナルシークエンス・トラップ法の応用

  中邨 智之; 松森 昭; 岩崎 篤志; 古川 裕; 篠山 重威; 矢部 大介; 金澤 伸雄; 本庶 佑

  Japanese circulation journal, 05 Mar. 1997

  
• 1025 マウス胎仔期心臓に発現する新たなカルシウム結合タンパクの単離とその解析

  中邨 智之; 松森 昭; 古川 裕; 塩井 哲雄; 篠山 重威; 矢部 大介; 本庶 佑

  Japanese circulation journal, 05 Mar. 1997

  
• シグナル・シークエンス・トラップ法を用いたマウス胎仔期心臓からの新たな小胞体カルシウム結合蛋白（calumenin）のクローニングとその解析

  矢部大介; 中邨智之; 金澤伸雄; 田代啓; 篠山重威; 本庶佑

  心筋の構造と代謝, 1997, Invited

  
• Molecular cloning and expression of a novel FK506-binding protein in murine embryonic heart by the signal sequence trap method

  T Nakamura; D Yabe; T Shioi; Y Furukawa; T Nakano; T Honjo

  CIRCULATION, Oct. 1996

  
• シグナルシークエンス・トラップ法を用いたマウス胎仔期心臓における細胞間シグナル分子のクローニング

  中邨 智之; 矢部 大介; 仲野 徹; 篠山 重威; 本庶 佑

  日本分子生物学会年会プログラム・講演要旨集, 01 Aug. 1996

  
• マウス胎仔期心臓からシグナル・シークエンス・トラップ法で単離された新たな細胞間シグナル分子の解析

  矢部 大介; 中邨 智之; 仲野 徹; 本庶 佑

  日本分子生物学会年会プログラム・講演要旨集, 01 Aug. 1996